-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 E43o4mD0yZssWBwj8/89xvort9DpBN9daDRx5XY1UQAlyPhHpW7O3UddarcfzNwZ
 BSESfbzCE8oR75oTAea+Ng==

<SEC-DOCUMENT>0001297077-08-000087.txt : 20080801
<SEC-HEADER>0001297077-08-000087.hdr.sgml : 20080801
<ACCEPTANCE-DATETIME>20080801172014
ACCESSION NUMBER:		0001297077-08-000087
CONFORMED SUBMISSION TYPE:	10-Q/A
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20080130
FILED AS OF DATE:		20080801
DATE AS OF CHANGE:		20080801

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CHAMPIONS BIOTECHNOLOGY, INC.
		CENTRAL INDEX KEY:			0000771856
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				521401755
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0430

	FILING VALUES:
		FORM TYPE:		10-Q/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-17263
		FILM NUMBER:		08986017

	BUSINESS ADDRESS:	
		STREET 1:		2200 WILSON BLVD
		STREET 2:		SUITE 102-316
		CITY:			ARLINGTON
		STATE:			VA
		ZIP:			22201
		BUSINESS PHONE:		703-526-0400

	MAIL ADDRESS:	
		STREET 1:		2200 WILSON BLVD.
		STREET 2:		SUITE 102-316
		CITY:			ARLINGTON
		STATE:			VA
		ZIP:			22201

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHAMPIONS SPORTS INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTERNATIONAL GROUP INC
		DATE OF NAME CHANGE:	19860319
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q/A
<SEQUENCE>1
<FILENAME>cbi10qa_013108-2.htm
<TEXT>
<html>
<head><meta content="text/html; charset=">
<title>SECURITIES AND EXCHANGE COMMISSION</title>
</head>

<body >
<ul>
</ul>

<p>
<br></p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="666.666500" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>SECURITIES AND EXCHANGE COMMISSION</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="666.666500" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>Washington, D.C.  20549</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="666.666500" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="666.666500" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>FORM 10-QSB/A</b></font><br><font size="2"><b>(Amendment No. 1)</b></font></p align="center">
</td>
</tr>
</table></div>
<p>
</p>
<div align="center" style="position:relative; left: 0"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="541.333198" colspan="1" rowspan="1" >
<p>
<font size="2">Mark One</font></p>
</td>
</tr>
</table></div>
<p>
</p>
<div align="center" style="position:relative; left: 0"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="41.333323" colspan="1" rowspan="1" >
<p>
<font size="2">[X]</font></p>
</td>
<td width="419.999895" colspan="1" rowspan="1" >
<p>
<font size="2">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF</font></p>
</td>
</tr>
<tr valign="top">
<td width="41.333323" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="419.999895" colspan="1" rowspan="1" >
<p>
<font size="2">THE SECURITIES EXCHANGE ACT OF 1934</font></p>
</td>
</tr>
</table></div>
<p>
</p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="666.666500" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><u>For the quarterly period ended   January 31, 2008</u></font></p align="center">
</td>
</tr>
</table></div>
<p>
</p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="666.666500" colspan="1" rowspan="1" >
<p align="center">
<font size="2">OR</font></p align="center">
</td>
</tr>
</table></div>
<p>
</p>
<div align="center" style="position:relative; left: 0"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="41.333323" colspan="1" rowspan="1" >
<p>
<font size="2">[&nbsp;&nbsp;&nbsp;]</font></p>
</td>
<td width="419.999895" colspan="1" rowspan="1" >
<p>
<font size="2">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF</font></p>
</td>
</tr>
<tr valign="top">
<td width="41.333323" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="419.999895" colspan="1" rowspan="1" >
<p>
<font size="2">THE SECURITIES EXCHANGE ACT OF 1934</font></p>
</td>
</tr>
</table></div>
<p>
</p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="666.666500" colspan="1" rowspan="1" >
<p align="center">
<font size="2">For the transition period from    <u>                </u>&nbsp;&nbsp;to</font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="666.666500" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="666.666500" colspan="1" rowspan="1" >
<p align="center">
<font size="2">Commission file number            <u>&nbsp;0-17263</u></font></p align="center">
</td>
</tr>
</table></div>
<p>
<br></p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="666.666500" colspan="1" rowspan="1" >
<p align="center">
<b><u>CHAMPIONS BIOTECHNOLOGY, INC.</u></b></p align="center">
</td>
</tr>
<tr valign="top">
<td width="666.666500" colspan="1" rowspan="1" >
<p align="center">
<font size="2">(Exact name of registrant as specified in its charter)</font></p align="center">
</td>
</tr>
</table></div>
<p>
</p align="center">
<div align="center" style="position:relative; left: 0"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="323.999919" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><u>Delaware</u></font></p align="center">
</td>
<td width="329.333251" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><u>52-1401755</u></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="323.999919" colspan="1" rowspan="1" >
<p align="center">
<font size="2">(State or other jurisdiction of</font></p align="center">
</td>
<td width="329.333251" colspan="1" rowspan="1" >
<p align="center">
<font size="2">(I.R.S. Employer</font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="323.999919" colspan="1" rowspan="1" >
<p align="center">
<font size="2">organization)</font></p align="center">
</td>
<td width="329.333251" colspan="1" rowspan="1" >
<p align="center">
<font size="2">Identification No.)</font></p align="center">
</td>
</tr>
</table></div>
<p>
</p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="666.666500" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><u>1400 N. 14<sup>th</sup> Street, Arlington VA 22209</u></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="666.666500" colspan="1" rowspan="1" >
<p align="center">
<font size="2">(Address of principal executive offices)</font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="666.666500" colspan="1" rowspan="1" >
<p align="center">
<font size="2">(Zip code)</font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="666.666500" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="666.666500" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><u>(410) 630-1313</u></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="666.666500" colspan="1" rowspan="1" >
<p align="center">
<font size="2">(Registrant&#8217;s telephone number, including area code)</font></p align="center">
</td>
</tr>
</table></div>
<p>
</p>
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="666.666500" colspan="1" rowspan="1" >
<p>
<font size="2">Indicate by check mark whether the issuer (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities  Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),  and (2) has been subject to such filing requirements for the past 90 days.  Yes  <u>&nbsp;x    </u>&nbsp;&nbsp;No    <u>    </u>&nbsp;</font></p>
</td>
</tr>
<tr valign="top">
<td width="666.666500" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="666.666500" colspan="1" rowspan="1" >
<p>
<font size="2">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.) Yes __   No    <u>x    </u>&nbsp;&nbsp;</font></p>
</td>
</tr>
<tr valign="top">
<td width="666.666500" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="666.666500" colspan="1" rowspan="1" >
<p>
<font size="2">As of February 27, 2008 the Registrant had a total of 31,794,146 shares of common stock outstanding.</font></p>
</td>
</tr>
<tr valign="top">
<td width="666.666500" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="666.666500" colspan="1" rowspan="1" >
<p>
<font size="2">Transitional Small Business Disclosure Format (check one): &nbsp;&nbsp;Yes <u>&nbsp;x    </u>No    <u>&nbsp;</u></font></p>
</td>
</tr>
</table></div>
<p>
<br><br></p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="666.666500" colspan="1" rowspan="1" >
<p align="center" style="border-bottom:double">
<font size="2">&nbsp;</font></p>
</td>
</tr>
</table></div>
<p>
<p>
<font size="2">The Registrant hereby amends its Quarterly Report on Form 10-QSB
for the fiscal quarter ended January 31, 2008, which was filed with the
Commission on March 6, 2008, to correct the timing of recorded revenue.  As
previously filed, the Registrant recognized $1,174,940 in revenue ($.02 per
[basic/diluted] share) during its fiscal quarter ended January 31, 2008.  As
part of the Registrant&#8217;s due diligence in preparing its Annual Report on
Form 10-KSB for the fiscal year ended April 30, 2008, the Registrant
reclassified $300,000 of  revenues which it had previously recorded in the third
fiscal quarter and deferred and recognized it to the fourth fiscal quarter.
This increased the accumulated deficit from $6,630,234 to $6,930,234 and reduced
the earnings per share (basic/diluted) to $0.01.  This change had no impact on
the annual results for the year ended April 30, 2008 as reflected in the
registrant&#8217;s Annual Report on Form 10-KSB.</font></p>
<p>
<br></p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="666.666500" colspan="1" rowspan="1" >
<p align="center" style="border-bottom:double">
<font size="2">&nbsp;</font></p>
</td>
</tr>
</table></div>
<p>
</p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="666.666500" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>CHAMPIONS BIOTECHNOLOGY, INC.</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="666.666500" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>FORM 10-QSB</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="666.666500" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="666.666500" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><u>INDEX</u></font></p align="center">
</td>
</tr>
</table></div>
<p>
<br></p>
<div align="center" style="position:relative; left: 0"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="53.333320" colspan="1" rowspan="1" bgcolor=#99CCFF>
&nbsp;</td>
<td width="499.999875" colspan="1" rowspan="1" bgcolor=#99CCFF>
<p>
<font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p>
</td>
<td width="65.333317" colspan="1" rowspan="1" bgcolor=#99CCFF>
<p>
<font size="2"><u>Page</u></font></p>
</td>
</tr>
<tr valign="top">
<td width="53.333320" colspan="1" rowspan="1" >
<p>
<font size="2">Part I. </font></p>
</td>
<td width="499.999875" colspan="1" rowspan="1" >
<p>
<font size="2">Financial Information</font></p>
</td>
<td width="65.333317" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="619.999845" colspan="3" rowspan="1" bgcolor=#99CCFF>
&nbsp;</td>
</tr>
<tr valign="top">
<td width="53.333320" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="499.999875" colspan="1" rowspan="1" >
<p>
<font size="2">Item 1.&nbsp;&nbsp;&nbsp;Financial Statements</font></p>
</td>
<td width="65.333317" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="619.999845" colspan="3" rowspan="1" bgcolor=#99CCFF>
&nbsp;</td>
</tr>
<tr valign="top">
<td width="53.333320" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="499.999875" colspan="1" rowspan="1" >
<p>
<font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Condensed Consolidated Balance Sheet as of January 31, 2008 (Unaudited)</font></p>
</td>
<td width="65.333317" colspan="1" rowspan="1" >
<p>
<font size="2">5</font></p>
</td>
</tr>
<tr valign="top">
<td width="619.999845" colspan="3" rowspan="1" bgcolor=#99CCFF>
&nbsp;</td>
</tr>
<tr valign="top">
<td width="53.333320" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="499.999875" colspan="1" rowspan="1" >
<p>
<font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Condensed Consolidated Statements of Operations</font></p>
</td>
<td width="65.333317" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="53.333320" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="499.999875" colspan="1" rowspan="1" >
<p>
<font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;for the Nine months and Three months ended January 31, 2008 and  2007 (Unaudited)</font></p>
</td>
<td width="65.333317" colspan="1" rowspan="1" >
<p>
<font size="2">6</font></p>
</td>
</tr>
<tr valign="top">
<td width="619.999845" colspan="3" rowspan="1" bgcolor=#99CCFF>
&nbsp;</td>
</tr>
<tr valign="top">
<td width="53.333320" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="499.999875" colspan="1" rowspan="1" >
<p>
<font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Condensed Consolidated Statements of Cash Flows for the</font></p>
</td>
<td width="65.333317" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="53.333320" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="499.999875" colspan="1" rowspan="1" >
<p>
<font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nine months ended January 31, 2008 and  2007 (Unaudited)</font></p>
</td>
<td width="65.333317" colspan="1" rowspan="1" >
<p>
<font size="2">7</font></p>
</td>
</tr>
<tr valign="top">
<td width="53.333320" colspan="1" rowspan="1" bgcolor=#99CCFF>
&nbsp;</td>
<td width="499.999875" colspan="1" rowspan="1" bgcolor=#99CCFF>
&nbsp;</td>
<td width="65.333317" colspan="1" rowspan="1" bgcolor=#99CCFF>
&nbsp;</td>
</tr>
<tr valign="top">
<td width="53.333320" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="499.999875" colspan="1" rowspan="1" >
<p>
<font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notes to Condensed Consolidated Financial Statements (Unaudited)</font></p>
</td>
<td width="65.333317" colspan="1" rowspan="1" >
<p>
<font size="2">8-16</font></p>
</td>
</tr>
<tr valign="top">
<td width="619.999845" colspan="3" rowspan="1" bgcolor=#99CCFF>
&nbsp;</td>
</tr>
<tr valign="top">
<td width="53.333320" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="499.999875" colspan="1" rowspan="1" >
<p>
<font size="2">Item 2.&nbsp;&nbsp;&nbsp;Management&#8217;s Discussion and Analysis or Plan of Operation</font></p>
</td>
<td width="65.333317" colspan="1" rowspan="1" >
<p>
<font size="2">17-19</font></p>
</td>
</tr>
<tr valign="top">
<td width="53.333320" colspan="1" rowspan="1" bgcolor=#99CCFF>
&nbsp;</td>
<td width="499.999875" colspan="1" rowspan="1" bgcolor=#99CCFF>
&nbsp;</td>
<td width="65.333317" colspan="1" rowspan="1" bgcolor=#99CCFF>
&nbsp;</td>
</tr>
<tr valign="top">
<td width="53.333320" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="499.999875" colspan="1" rowspan="1" >
<p>
<font size="2">Item 3.&nbsp;&nbsp;&nbsp;Controls and Procedures</font></p>
</td>
<td width="65.333317" colspan="1" rowspan="1" >
<p>
<font size="2">19</font></p>
</td>
</tr>
<tr valign="top">
<td width="53.333320" colspan="1" rowspan="1" bgcolor=#99CCFF>
&nbsp;</td>
<td width="499.999875" colspan="1" rowspan="1" bgcolor=#99CCFF>
&nbsp;</td>
<td width="65.333317" colspan="1" rowspan="1" bgcolor=#99CCFF>
&nbsp;</td>
</tr>
<tr valign="top">
<td width="53.333320" colspan="1" rowspan="1" >
<p>
<font size="2">Part II.</font></p>
</td>
<td width="499.999875" colspan="1" rowspan="1" >
<p>
<font size="2">Other Information and Signatures</font></p>
</td>
<td width="65.333317" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="53.333320" colspan="1" rowspan="1" bgcolor=#99CCFF>
&nbsp;</td>
<td width="499.999875" colspan="1" rowspan="1" bgcolor=#99CCFF>
<p>
<font size="2">Item 6.&nbsp;&nbsp;&nbsp;Exhibits </font></p>
</td>
<td width="65.333317" colspan="1" rowspan="1" bgcolor=#99CCFF>
<p>
<font size="2">20</font></p>
</td>
</tr>
<tr valign="top">
<td width="53.333320" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="499.999875" colspan="1" rowspan="1" >
<p>
<font size="2">Signatures</font></p>
</td>
<td width="65.333317" colspan="1" rowspan="1" >
<p>
<font size="2">21</font></p>
</td>
</tr>
<tr valign="top">
<td width="53.333320" colspan="1" rowspan="1" bgcolor=#99CCFF>
&nbsp;</td>
<td width="499.999875" colspan="1" rowspan="1" bgcolor=#99CCFF>
&nbsp;</td>
<td width="65.333317" colspan="1" rowspan="1" bgcolor=#99CCFF>
&nbsp;</td>
</tr>
<tr valign="top">
<td width="554.666528" colspan="2" rowspan="1" >
<p>
<font size="2">Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</font></p>
</td>
<td width="65.333317" colspan="1" rowspan="1" >
<p>
<font size="2">22</font></p>
</td>
</tr>
<tr valign="top">
<td width="554.666528" colspan="2" rowspan="1" bgcolor=#99CCFF>
<p>
<font size="2">Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</font></p>
</td>
<td width="65.333317" colspan="1" rowspan="1" bgcolor=#99CCFF>
<p>
<font size="2">23</font></p>
</td>
</tr>
<tr valign="top">
<td width="554.666528" colspan="2" rowspan="1" >
<p>
<font size="2">Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</font></p>
</td>
<td width="65.333317" colspan="1" rowspan="1" >
<p>
<font size="2">24</font></p>
</td>
</tr>
</table></div>
<p>
<br><br></p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="666.666500" colspan="1" rowspan="1" >
<p align="center" style="border-bottom:double">
<font size="2">2</font></p>
</td>
</tr>
</table></div>
<p>
<br><br><br><br><br><br><br><br><br><br></p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="666.666500" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="666.666500" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>CHAMPIONS BIOTECHNOLOGY, INC. AND SUBSIDIARIES</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="666.666500" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>(FORMERLY CHAMPIONS SPORTS, INC. AND SUBSIDIARIES)</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="666.666500" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="666.666500" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>JANUARY 31, 2008 AND 2007 (UNAUDITED)</b></font></p align="center">
</td>
</tr>
</table></div>
<p>
<br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br><br></p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="666.666500" colspan="1" rowspan="1" >
<p align="center" style="border-bottom:double">
<font size="2">3</font></p>
</td>
</tr>
</table></div>
<p>
<br><br></p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="563.999859" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>CHAMPIONS BIOTECHNOLOGY, INC. AND SUBSIDIARIES</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="563.999859" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>(FORMERLY CHAMPIONS SPORTS, INC. AND SUBSIDIARIES)</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="563.999859" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>INDEX TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="563.999859" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>JANUARY 31, 2008 AND 2007 (UNAUDITED)</b></font></p align="center">
</td>
</tr>
</table></div>
<p>
<br><br><br></p>
<div align="center" style="position:relative; left: 0"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="545.333197" colspan="3" rowspan="1" >
<p>
<font size="2">CONDENSED CONSOLIDATED FINANCIAL STATEMENTS:</font></p>
</td>
</tr>
<tr valign="top">
<td width="545.333197" colspan="3" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="545.333197" colspan="3" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="509.333206" colspan="2" rowspan="1" >
<p>
<font size="2">Condensed Consolidated Balance Sheet as of January 31, 2008 (Unaudited) </font></p>
</td>
<td width="35.999991" colspan="1" rowspan="1" >
<p>
<font size="2">5</font></p>
</td>
</tr>
<tr valign="top">
<td width="545.333197" colspan="3" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="545.333197" colspan="3" rowspan="1" >
<p>
<font size="2">Condensed Consolidated Statements of Operations for the Nine months and Three months </font></p>
</td>
</tr>
<tr valign="top">
<td width="23.999994" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="485.333212" colspan="1" rowspan="1" >
<p>
<font size="2">ended January 31, 2008 and 2007 (Unaudited)    </font></p>
</td>
<td width="35.999991" colspan="1" rowspan="1" >
<p>
<font size="2">6</font></p>
</td>
</tr>
<tr valign="top">
<td width="545.333197" colspan="3" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="545.333197" colspan="3" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="545.333197" colspan="3" rowspan="1" >
<p>
<font size="2">Condensed Consolidated Statements of Cash Flows for the Nine months ended</font></p>
</td>
</tr>
<tr valign="top">
<td width="23.999994" colspan="1" rowspan="1" >
<p>
<font size="2"> </font></p>
</td>
<td width="485.333212" colspan="1" rowspan="1" >
<p>
<font size="2">January 31, 2008 and 2007 (Unaudited)       </font></p>
</td>
<td width="35.999991" colspan="1" rowspan="1" >
<p>
<font size="2">7</font></p>
</td>
</tr>
<tr valign="top">
<td width="545.333197" colspan="3" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="545.333197" colspan="3" rowspan="1" >
<p>
<font size="2">  </font></p>
</td>
</tr>
<tr valign="top">
<td width="545.333197" colspan="3" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="509.333206" colspan="2" rowspan="1" >
<p>
<font size="2">Notes to Condensed Consolidated Financial Statements (Unaudited)    </font></p>
</td>
<td width="35.999991" colspan="1" rowspan="1" >
<p>
<font size="2">8-16</font></p>
</td>
</tr>
</table></div>
<p>
<br><br></p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="685.333162" colspan="1" rowspan="1" >
<p align="center" style="border-bottom:double">
<font size="2">4</font></p>
</td>
</tr>
</table></div>
<p>
<br></p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="582.666521" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="582.666521" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>CHAMPIONS BIOTECHNOLOGY, INC. AND SUBSIDIARIES</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="582.666521" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>(FORMERLY CHAMPIONS SPORTS, INC. AND SUBSIDIARIES)</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="582.666521" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>CONDENSED CONSOLIDATED BALANCE SHEET</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="582.666521" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>AS OF JANUARY 31, 2008 (UNAUDITED)</b></font></p align="center">
</td>
</tr>
</table></div>
<p>
</p>
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="370.666574" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="417.333229" colspan="4" rowspan="1" >
<p>
<font size="2"><b>ASSETS</b></font></p>
</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="370.666574" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
<p align="center" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>(Restated)</b></font></p>
</td>
</tr>
<tr valign="top">
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="370.666574" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="401.333233" colspan="3" rowspan="1" >
<p>
<font size="2"><b>CURRENT ASSETS</b></font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="386.666570" colspan="2" rowspan="1" >
<p>
<font size="2">Cash and cash equivalents</font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>$&nbsp;&nbsp;&nbsp;1,072,453 </b></font></p>
</td>
</tr>
<tr valign="top">
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="386.666570" colspan="2" rowspan="1" >
<p>
<font size="2">Supplies</font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>47,466 </b></font></p>
</td>
</tr>
<tr valign="top">
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="370.666574" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="370.666574" colspan="1" rowspan="1" >
<p>
<font size="2"><b>Total Current Assets</b></font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
<p align="right">
<font size="2">1,119,919 </font></p align="right">
</td>
</tr>
<tr valign="top">
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="370.666574" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="386.666570" colspan="2" rowspan="1" >
<p>
<font size="2">Intangibles assets</font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
<p align="right">
<font size="2">191,745 </font></p align="right">
</td>
</tr>
<tr valign="top">
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="386.666570" colspan="2" rowspan="1" >
<p>
<font size="2">Goodwill</font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>661,909 </b></font></p>
</td>
</tr>
<tr valign="top">
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="370.666574" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="401.333233" colspan="3" rowspan="1" >
<p>
<font size="2"><b>TOTAL ASSETS</b></font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:double">
<font size="2"><b><i>$&nbsp;&nbsp;&nbsp;1,973,573 </i></b></font></p>
</td>
</tr>
<tr valign="top">
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="370.666574" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="417.333229" colspan="4" rowspan="1" >
<p>
<font size="2"><b>LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</b></font></p>
</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="370.666574" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="401.333233" colspan="3" rowspan="1" >
<p>
<font size="2"><b>CURRENT LIABILITIES</b></font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="386.666570" colspan="2" rowspan="1" >
<p>
<font size="2">Accounts payable</font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
<p align="right">
<font size="2">$&nbsp;&nbsp;&nbsp;111,778 </font></p align="right">
</td>
</tr>
<tr valign="top">
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="386.666570" colspan="2" rowspan="1" >
<p>
<font size="2">Deferred revenue</font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>300,000</b></font></p>
</td>
</tr>
<tr valign="top">
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="386.666570" colspan="2" rowspan="1" >
<p>
<font size="2">Other accrued expenses</font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>351,394 </b></font></p>
</td>
</tr>
<tr valign="top">
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="370.666574" colspan="1" rowspan="1" >
<p>
<font size="2"><b>Total current liabilities</b></font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>763,172 </b></font></p>
</td>
</tr>
<tr valign="top">
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="370.666574" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="401.333233" colspan="3" rowspan="1" >
<p>
<font size="2"><b>COMMITMENTS AND CONTINGENCIES</b></font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="370.666574" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="401.333233" colspan="3" rowspan="1" >
<p>
<font size="2"><b>STOCKHOLDERS&#8217; EQUITY</b></font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="386.666570" colspan="2" rowspan="1" >
<p>
<font size="2">Common stock, $.001 par value; 50,000,000 shares authorized;</font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="386.666570" colspan="2" rowspan="1" >
<p>
<font size="2">31,794,146 shares issued and outstanding</font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
<p align="right">
<font size="2">31,794 </font></p align="right">
</td>
</tr>
<tr valign="top">
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="386.666570" colspan="2" rowspan="1" >
<p>
<font size="2">Additional paid-in capital</font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
<p align="right">
<font size="2">8,526,789 </font></p align="right">
</td>
</tr>
<tr valign="top">
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="386.666570" colspan="2" rowspan="1" >
<p>
<font size="2">Accumulated deficit</font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b> (6,930,234)</b></font></p>
</td>
</tr>
<tr valign="top">
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="370.666574" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
<p align="right">
<font size="2">1,628,349 </font></p align="right">
</td>
</tr>
<tr valign="top">
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="386.666570" colspan="2" rowspan="1" >
<p>
<font size="2">Less: prepaid consulting</font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b> (417,948)</b></font></p>
</td>
</tr>
<tr valign="top">
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="386.666570" colspan="2" rowspan="1" >
<p>
<font size="2">Total stockholders&#8217; equity</font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
<p align="right">
<font size="2">1,210,401 </font></p align="right">
</td>
</tr>
<tr valign="top">
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="370.666574" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="401.333233" colspan="3" rowspan="1" >
<p>
<font size="2"><b>TOTAL LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</b></font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:double">
<font size="2"><b><i>$&nbsp;&nbsp;&nbsp;1,973,573 </i></b></font></p>
</td>
</tr>
</table></div>
<p>
</p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="685.333162" colspan="1" rowspan="1" >
<p align="center">
<font size="2">The accompanying notes are an integral part of these condensed consolidated financial statements</font></p align="center">
</td>
</tr>
</table></div>
<p>
<br><br></p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="685.333162" colspan="1" rowspan="1" >
<p align="center" style="border-bottom:double">
<font size="2">5</font></p>
</td>
</tr>
</table></div>
<p>
<br></p>
<p>
</p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="755.999811" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>CHAMPIONS BIOTECHNOLOGY, INC. AND SUBSIDIARIES</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="755.999811" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>(FORMERLY CHAMPIONS SPORTS, INC. AND SUBSIDIARIES)</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="755.999811" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="755.999811" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>FOR THE NINE MONTHS AND THREE MONTHS ENDED JANUARY 31, 2008 AND 2007 (UNAUDITED)</b></font></p align="center">
</td>
</tr>
</table></div>
<p>
</p>
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="89.333311" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="142.666631" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="87.999978" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="34.666658" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="27.999993" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="173.333290" colspan="3" rowspan="1" >
<p align="center">
<font size="2"><b>Nine Months Ended January 31</b></font></p align="center">
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="189.333286" colspan="3" rowspan="1" >
<p align="center">
<font size="2"><b>Three Months Ended January 31</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="89.333311" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="142.666631" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="87.999978" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="34.666658" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="27.999993" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="89.333311" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>(Restated)</b></font></p align="center">
</td>
<td width="18.666662" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="63.999984" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="87.999978" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>(Restated)</b></font></p align="center">
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="82.666646" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="89.333311" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="142.666631" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="87.999978" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="34.666658" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="27.999993" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="89.333311" colspan="1" rowspan="1" >
<p align="center" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>2008</b></font></p>
</td>
<td width="18.666662" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="63.999984" colspan="1" rowspan="1" >
<p align="center" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>2007</b></font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="87.999978" colspan="1" rowspan="1" >
<p align="center" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>2008</b></font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="82.666646" colspan="1" rowspan="1" >
<p align="center" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>2007</b></font></p>
</td>
</tr>
<tr valign="top">
<td width="89.333311" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="142.666631" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="87.999978" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="34.666658" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="27.999993" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="89.333311" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="18.666662" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="63.999984" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="87.999978" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="82.666646" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="319.999920" colspan="3" rowspan="1" >
<p>
<font size="2"><b>OPERATING REVENUE</b></font></p>
</td>
<td width="34.666658" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="27.999993" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="89.333311" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="18.666662" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="63.999984" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="87.999978" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="82.666646" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="89.333311" colspan="1" rowspan="1" >
<p>
<font size="2">    &nbsp;Services</font></p>
</td>
<td width="142.666631" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="87.999978" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="34.666658" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="27.999993" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="89.333311" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>$&nbsp;&nbsp;&nbsp;874,940 </b></font></p>
</td>
<td width="18.666662" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="63.999984" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>$&nbsp;&nbsp;&nbsp;-   </b></font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="87.999978" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>$&nbsp;&nbsp;&nbsp;624,940   </b></font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="82.666646" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>$&nbsp;&nbsp;&nbsp;-   </b></font></p>
</td>
</tr>
<tr valign="top">
<td width="89.333311" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="142.666631" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="87.999978" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="34.666658" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="27.999993" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="89.333311" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="18.666662" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="63.999984" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="87.999978" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="82.666646" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="89.333311" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="266.666600" colspan="3" rowspan="1" >
<p>
<font size="2"><b>Total operating revenue</b></font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="27.999993" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="89.333311" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>874,940 </b></font></p>
</td>
<td width="18.666662" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="63.999984" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>-   </b></font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="87.999978" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>624,940   </b></font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="82.666646" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>-   </b></font></p>
</td>
</tr>
<tr valign="top">
<td width="89.333311" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="142.666631" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="87.999978" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="34.666658" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="27.999993" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="89.333311" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="18.666662" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="63.999984" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="87.999978" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="82.666646" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="355.999911" colspan="4" rowspan="1" >
<p>
<font size="2"><b>COSTS AND OPERATING EXPENSES </b></font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="27.999993" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="89.333311" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="18.666662" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="63.999984" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="87.999978" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="82.666646" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="231.999942" colspan="2" rowspan="1" >
<p>
<font size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</b>Service expenses</font></p>
</td>
<td width="87.999978" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="34.666658" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="27.999993" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="89.333311" colspan="1" rowspan="1" >
<p align="right">
<font size="2">264,262</font></p align="right">
</td>
<td width="18.666662" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="63.999984" colspan="1" rowspan="1" >
<p align="right">
<font size="2">-</font></p align="right">
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="87.999978" colspan="1" rowspan="1" >
<p align="right">
<font size="2">201,222</font></p align="right">
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="82.666646" colspan="1" rowspan="1" >
<p align="right">
<font size="2">-</font></p align="right">
</td>
</tr>
<tr valign="top">
<td width="231.999942" colspan="2" rowspan="1" >
<p>
<font size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</b>Supplies</font></p>
</td>
<td width="87.999978" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="34.666658" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="27.999993" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="89.333311" colspan="1" rowspan="1" >
<p align="right">
<font size="2">75,000 </font></p align="right">
</td>
<td width="18.666662" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="63.999984" colspan="1" rowspan="1" >
<p align="right">
<font size="2">-   </font></p align="right">
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="87.999978" colspan="1" rowspan="1" >
<p align="right">
<font size="2">-   </font></p align="right">
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="82.666646" colspan="1" rowspan="1" >
<p align="right">
<font size="2">-   </font></p align="right">
</td>
</tr>
<tr valign="top">
<td width="319.999920" colspan="3" rowspan="1" >
<p>
<font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General and administrative</font></p>
</td>
<td width="34.666658" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="27.999993" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="89.333311" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>377,724 </b></font></p>
</td>
<td width="18.666662" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="63.999984" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>74,086 </b></font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="87.999978" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>118,776 </b></font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="82.666646" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>37,198 </b></font></p>
</td>
</tr>
<tr valign="top">
<td width="89.333311" colspan="1" rowspan="1" >
<p align="right">
<font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></p align="right">
</td>
<td width="142.666631" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="87.999978" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="34.666658" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="27.999993" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="89.333311" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="18.666662" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="63.999984" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="87.999978" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="82.666646" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="89.333311" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="266.666600" colspan="3" rowspan="1" >
<p>
<font size="2"><b>Total costs and operating expenses</b></font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="27.999993" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="89.333311" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>716,986 </b></font></p>
</td>
<td width="18.666662" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="63.999984" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>74,086 </b></font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="87.999978" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>319,998 </b></font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="82.666646" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>37,198 </b></font></p>
</td>
</tr>
<tr valign="top">
<td width="89.333311" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="142.666631" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="87.999978" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="34.666658" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="27.999993" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="89.333311" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="18.666662" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="63.999984" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="87.999978" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="82.666646" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="355.999911" colspan="4" rowspan="1" >
<p>
<font size="2"><b>INCOME (LOSS) BEFORE OTHER INCOME</b></font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="27.999993" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="89.333311" colspan="1" rowspan="1" >
<p align="right">
<font size="2">157,954</font></p align="right">
</td>
<td width="18.666662" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="63.999984" colspan="1" rowspan="1" >
<p align="right">
<font size="2"> (74,086)</font></p align="right">
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="87.999978" colspan="1" rowspan="1" >
<p align="right">
<font size="2"> 304,942</font></p align="right">
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="82.666646" colspan="1" rowspan="1" >
<p align="right">
<font size="2"> (37,198)</font></p align="right">
</td>
</tr>
<tr valign="top">
<td width="89.333311" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="142.666631" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="87.999978" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="34.666658" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="27.999993" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="89.333311" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="18.666662" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="63.999984" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="87.999978" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="82.666646" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="231.999942" colspan="2" rowspan="1" >
<p>
<font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other income</font></p>
</td>
<td width="87.999978" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="34.666658" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="27.999993" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="89.333311" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="18.666662" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="63.999984" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="87.999978" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="82.666646" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="89.333311" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="230.666609" colspan="2" rowspan="1" >
<p>
<font size="2">Interest income</font></p>
</td>
<td width="34.666658" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="27.999993" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="89.333311" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>16,057 </b></font></p>
</td>
<td width="18.666662" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="63.999984" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>-   </b></font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="87.999978" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>6,064 </b></font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="82.666646" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>&nbsp;&nbsp;&nbsp;-   </b></font></p>
</td>
</tr>
<tr valign="top">
<td width="89.333311" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="230.666609" colspan="2" rowspan="1" >
<p>
<font size="2"><b>Total other income</b></font></p>
</td>
<td width="34.666658" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="27.999993" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="89.333311" colspan="1" rowspan="1" >
<p align="right">
<font size="2">16,057 </font></p align="right">
</td>
<td width="18.666662" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="63.999984" colspan="1" rowspan="1" >
<p align="right">
<font size="2">-   </font></p align="right">
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="87.999978" colspan="1" rowspan="1" >
<p align="right">
<font size="2">6,064 </font></p align="right">
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="82.666646" colspan="1" rowspan="1" >
<p align="right">
<font size="2">-   </font></p align="right">
</td>
</tr>
<tr valign="top">
<td width="89.333311" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="142.666631" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="87.999978" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="34.666658" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="27.999993" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="89.333311" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="18.666662" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="63.999984" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="87.999978" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="82.666646" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="371.999907" colspan="5" rowspan="1" >
<p>
<font size="2"><b>INCOME (LOSS) BEFORE PROVISION FOR INCOME TAXES</b></font></p>
</td>
<td width="27.999993" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="89.333311" colspan="1" rowspan="1" >
<p align="right">
<font size="2"> 174,011</font></p align="right">
</td>
<td width="18.666662" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="63.999984" colspan="1" rowspan="1" >
<p align="right">
<font size="2"> (74,086)</font></p align="right">
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="87.999978" colspan="1" rowspan="1" >
<p align="right">
<font size="2"> 311,006</font></p align="right">
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="82.666646" colspan="1" rowspan="1" >
<p align="right">
<font size="2"> (37,198)</font></p align="right">
</td>
</tr>
<tr valign="top">
<td width="319.999920" colspan="3" rowspan="1" >
<p>
<font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Provision for income taxes</font></p>
</td>
<td width="34.666658" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="27.999993" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="89.333311" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>-   </b></font></p>
</td>
<td width="18.666662" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="63.999984" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>-   </b></font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="87.999978" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>-   </b></font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="82.666646" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>-   </b></font></p>
</td>
</tr>
<tr valign="top">
<td width="89.333311" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="142.666631" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="87.999978" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="34.666658" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="27.999993" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="89.333311" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="18.666662" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="63.999984" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="87.999978" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="82.666646" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="399.999900" colspan="6" rowspan="1" >
<p>
<font size="2"><b>NET INCOME (LOSS) APPLICABLE TO COMMON STOCKHOLDERS</b></font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="89.333311" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:double">
<font size="2"><b><i>$    174,011</i></b></font></p>
</td>
<td width="18.666662" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="63.999984" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:double">
<font size="2"><b><i>$    (74,086)</i></b></font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="87.999978" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:double">
<font size="2"><b><i>$    311,006</i></b></font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="82.666646" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:double">
<font size="2"><b><i>$    (37,198)</i></b></font></p>
</td>
</tr>
<tr valign="top">
<td width="89.333311" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="142.666631" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="87.999978" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="34.666658" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="27.999993" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="89.333311" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="18.666662" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="63.999984" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="87.999978" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="82.666646" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="371.999907" colspan="5" rowspan="1" >
<p>
<font size="2"><b>BASIC AND DILUTED INCOME (LOSS) PER COMMON SHARE</b></font></p>
</td>
<td width="27.999993" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="89.333311" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:double">
<font size="2"><b><i>$    0.01</i></b></font></p>
</td>
<td width="18.666662" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="63.999984" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:double">
<font size="2"><b><i>$    (0.00)</i></b></font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="87.999978" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:double">
<font size="2"><b><i>$    0.01</i></b></font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="82.666646" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:double">
<font size="2"><b><i>$    (0.00)</i></b></font></p>
</td>
</tr>
<tr valign="top">
<td width="89.333311" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="142.666631" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="87.999978" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="34.666658" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="27.999993" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="89.333311" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="18.666662" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="63.999984" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="87.999978" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="82.666646" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="399.999900" colspan="6" rowspan="1" >
<p>
<font size="2"><b>WEIGHTED AVERAGE SHARES OUTSTANDING (BASIC) </b></font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="89.333311" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:double">
<font size="2"><b><i>31,386,454 </i></b></font></p>
</td>
<td width="18.666662" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="63.999984" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:double">
<font size="2"><b><i>20,489,493 </i></b></font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="87.999978" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:double">
<font size="2"><b><i>31,692,654 </i></b></font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="82.666646" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:double">
<font size="2"><b><i>18,091,931 </i></b></font></p>
</td>
</tr>
<tr valign="top">
<td width="399.999900" colspan="6" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="89.333311" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="18.666662" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="63.999984" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="87.999978" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="82.666646" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="399.999900" colspan="6" rowspan="1" >
<p>
<font size="2"><b>WEIGHTED AVERAGE SHARES OUTSTANDING (DILUTED)</b></font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="89.333311" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:double">
<font size="2"><b><i>32,468,344</i></b></font></p>
</td>
<td width="18.666662" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="63.999984" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:double">
<font size="2"><b><i>-</i></b></font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="87.999978" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:double">
<font size="2"><b><i>32,774,544</i></b></font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="82.666646" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:double">
<font size="2"><b><i>-</i></b></font></p>
</td>
</tr>
</table></div>
<p>
<br></p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="973.333090" colspan="1" rowspan="1" >
<p align="center">
<font size="2">The accompanying notes are an integral part of these condensed consolidated financial statements</font></p align="center">
</td>
</tr>
</table></div>
<p>
<br><br></p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="973.333090" colspan="1" rowspan="1" >
<p align="center" style="border-bottom:double">
<font size="2">6</font></p>
</td>
</tr>
</table></div>
<p>
<br></p>
<p>
</p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>CHAMPIONS BIOTECHNOLOGY, INC. AND SUBSIDIARIES</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>(FORMERLY CHAMPIONS SPORTS, INC. AND SUBSIDIARIES)</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>FOR THE NINE MONTHS ENDED JANUARY 31, 2008 AND 2007 (UNAUDITED)</b></font></p align="center">
</td>
</tr>
</table></div>
<p>
<br></p>
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="503.999874" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>(Restated)</b></font></p align="center">
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="503.999874" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>2008</b></font></p align="center">
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>2007</b></font></p align="center">
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="503.999874" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="503.999874" colspan="1" rowspan="1" >
<p>
<font size="2"><b>CASH FLOWS FROM OPERATING ACTIVITIES</b></font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="503.999874" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="503.999874" colspan="1" rowspan="1" >
<p>
<font size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income (loss)</b></font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>$    174,011</b></font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>$    (74,086)</b></font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="503.999874" colspan="1" rowspan="1" >
<p>
<font size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjustments to reconcile net (loss) to net cash</b></font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="503.999874" colspan="1" rowspan="1" >
<p>
<font size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Provided by (used in) operating activities:</b></font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="503.999874" colspan="1" rowspan="1" >
<p>
<font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Increase) in supplies</font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
<p align="right">
<font size="2">(47,466)</font></p align="right">
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
<p align="right">
<font size="2">-  </font></p align="right">
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="503.999874" colspan="1" rowspan="1" >
<p>
<font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Increase (decrease) in accounts payable</font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
<p align="right">
<font size="2">61,268 </font></p align="right">
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
<p align="right">
<font size="2"> (11,589)</font></p align="right">
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="503.999874" colspan="1" rowspan="1" >
<p>
<font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Increase in deferred revenue</font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
<p align="right">
<font size="2">300,000</font></p align="right">
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
<p align="right">
<font size="2">-</font></p align="right">
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="503.999874" colspan="1" rowspan="1" >
<p>
<font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Increase (decrease) in other accrued expenses</font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
<p align="right">
<font size="2">15,743</font></p align="right">
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
<p align="right">
<font size="2">24,221   </font></p align="right">
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="503.999874" colspan="1" rowspan="1" >
<p>
<font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of prepaid consulting services</font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>108,950 </b></font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>-   </b></font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="503.999874" colspan="1" rowspan="1" >
<p>
<font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total adjustments</font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>438,495</b></font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b> 12,632</b></font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="503.999874" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="503.999874" colspan="1" rowspan="1" >
<p>
<font size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by (used in)  operating activities</b></font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>612,506</b></font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b> (61,454)</b></font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="503.999874" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="503.999874" colspan="1" rowspan="1" >
<p>
<font size="2"><b>CASH FLOWS FROM FINANCING ACTIVITIES</b></font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="503.999874" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="503.999874" colspan="1" rowspan="1" >
<p>
<font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Payment of) proceeds from officers loan</font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
<p align="right">
<font size="2"> (43,693)</font></p align="right">
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
<p align="right">
<font size="2">43,693 </font></p align="right">
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="503.999874" colspan="1" rowspan="1" >
<p>
<font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sale of restricted common stock</font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>&nbsp;28,505</b></font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>&nbsp;38,000</b></font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="503.999874" colspan="1" rowspan="1" >
<p>
<font size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by (used in) financing activities</b></font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>(15,188)</b></font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>81,693 </b></font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="503.999874" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="503.999874" colspan="1" rowspan="1" >
<p>
<font size="2"><b>NET INCREASE  IN CASH AND</b></font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="503.999874" colspan="1" rowspan="1" >
<p>
<font size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CASH EQUIVALENTS</b></font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
<p align="right">
<font size="2"> 597,318</font></p align="right">
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
<p align="right">
<font size="2">20,239</font></p align="right">
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="503.999874" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="503.999874" colspan="1" rowspan="1" >
<p>
<font size="2"><b>CASH AND CASH EQUIVALENTS -</b></font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="503.999874" colspan="1" rowspan="1" >
<p>
<font size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;BEGINNING OF PERIOD</b></font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>475,135 </b></font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:solid windowtext .5pt">
<font size="2"><b>540 </b></font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="503.999874" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
<p align="right">
<font size="2">&nbsp;</font></p align="right">
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
<p align="right">
<font size="2">&nbsp;</font></p align="right">
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="503.999874" colspan="1" rowspan="1" >
<p>
<font size="2"><b>CASH AND CASH EQUIVALENTS - END OF PERIOD</b></font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:double">
<font size="2"><b><i>$&nbsp;&nbsp;&nbsp;1,072,453 </i></b></font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:double">
<font size="2"><b><i>$20,779 </i></b></font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="503.999874" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="503.999874" colspan="1" rowspan="1" >
<p>
<font size="2"><b>SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:</b></font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="503.999874" colspan="1" rowspan="1" >
<p>
<font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash paid during the year for:</font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="503.999874" colspan="1" rowspan="1" >
<p>
<font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest paid</font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:double">
<font size="2"><b><i>$&nbsp;&nbsp;&nbsp;-   </i></b></font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:double">
<font size="2"><b><i>$&nbsp;&nbsp;&nbsp;2,277   </i></b></font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="503.999874" colspan="1" rowspan="1" >
<p>
<font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income taxes paid</font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:double">
<font size="2"><b><i>$&nbsp;&nbsp;&nbsp;-   </i></b></font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:double">
<font size="2"><b><i>$&nbsp;&nbsp;&nbsp;-   </i></b></font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="503.999874" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="503.999874" colspan="1" rowspan="1" >
<p>
<font size="2"><b>SUPPLEMENTAL SCHEDULE OF NON-CASH FLOW INVESTING AND FINANCING ACTIVITIES:</b></font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="503.999874" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="503.999874" colspan="1" rowspan="1" >
<p>
<font size="2">In January 2007, the Company issued 340,000 stock options for prepaid consulting services valued at $44,184.</font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:double">
<font size="2"><b><i>   </i></b></font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
<p align="right" style="border-bottom:double">
<font size="2"><b><i> </i></b></font></p>
</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="503.999874" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="503.999874" colspan="1" rowspan="1" >
<p>
<font size="2">In May 2007, the Company issued 525,000 stock-options for prepaid consulting services valued at $157,473. </font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="503.999874" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="503.999874" colspan="1" rowspan="1" >
<p>
<font size="2">In May 2007, the Company issued 4,000,000 shares for 100% of the shares of Biomerk, Inc.</font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="503.999874" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="83.999979" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="522.666536" colspan="2" rowspan="1" >
<p>
<font size="2">In October 2007, the Company issued 500,000 stock options for prepaid consulting services valued at $336,287.</font></p>
</td>
<td width="83.999979" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="73.333315" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="698.666492" colspan="5" rowspan="1" >
&nbsp;</td>
<td width="14.666663" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
</table></div>
<p>
</p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2">The accompanying notes are an integral part of these condensed consolidated financial statements\</font></p align="center">
</td>
</tr>
</table></div>
<p>
<br><br></p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center" style="border-bottom:double">
<font size="2">7</font></p>
</td>
</tr>
</table></div>
<p>
<br></p>
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>CHAMPIONS BIOTECHNOLOGY, INC. AND SUBSIDIARIES</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>(FORMERLY CHAMPIONS SPORTS, INC. AND SUBSIDIARIES)</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>JANUARY 31, 2008 AND 2007 (UNAUDITED)</b></font></p align="center">
</td>
</tr>
</table></div>
<p>
<br><br><font size="2"><b>NOTE 1 - <u>ORGANIZATION AND BASIS OF PRESENTATION</u></b></font><br><br><font size="2">Champions Biotechnology, Inc., (the "Company") is a biotechnology company that is engaged in the development  of advanced preclinical  platforms and predictive tumor specific data to  enhance  and accelerate the value of oncology drugs  for companies and physicians. The  Company was incorporated under the laws of the State of Delaware in June 1985 as a merger and acquisition company under the name  "International Group, Inc." In September 1985, the Company completed a public offering, and in January 1986, acquired the world-wide rights to  the Champions sports theme restaurant concept and subsequently changed its name to "Champions Sports, Inc." In 1997, the Company sold its  Champions service mark and concept for sports themed restaurants to Marriott International, Inc. and since then until January 2007, had been  seeking a new business direction. In January 2007, the Company changed its name to
 Champions Biotechnology, Inc. to reflect the decision of  the Company to focus on biotechnology. In May 2007, the Company acquired Biomerk, Inc., a privately owned company focused on generating a  novel preclinical platform of human cancer tumor immune-deficient mice xenografts (Biomerk Tumorgrafts&#8482;).</font><br><br><font size="2">The condensed unaudited interim consolidated financial statements included herein have been prepared, without audit, pursuant to the rules and  regulations of the Securities and Exchange Commission. The condensed consolidated financial statements and notes are presented as permitted  on Form 10-QSB and do not contain information included in the Company&#8217;s annual statements and notes. Certain information and footnote  disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States  of America have been condensed or omitted pursuant to such rules and regulations, although the Company believes t
hat the disclosures are  adequate to make the information presented not misleading. It is suggested that these condensed consolidated financial statements be read in  conjunction with the April 30, 2007 audited consolidated financial statements and the accompanying notes thereto. While management believes  the procedures followed in preparing these condensed consolidated financial statements are reasonable, the accuracy of the amounts are in some  respects dependent upon the facts that will exist, and procedures that will be accomplished by the Company later in the year.</font><br><br><font size="2">These condensed unaudited consolidated financial statements reflect all adjustments, including normal recurring adjustments, which, in the  opinion of management, are necessary to present fairly the operations and cash flows for the period presented.</font><br><br><font size="2">As stated in Note 8, the Company has amended its previously issued condensed consolidated financial statements for the three months ende
d January 31, 2008 to reclassify $300,000 as deferred revenue previously recorded as revenue.  The effect of this change resulted in a reduction of net income for the three months ended January 31, 2008 of $300,000 to net income of $174,011 and an increase in the accumulated deficit to $6,930,234.</font><br><br><br></p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center" style="border-bottom:double">
<font size="2">8</font></p>
</td>
</tr>
</table></div>
<p>
<br></p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>CHAMPIONS BIOTECHNOLOGY, INC. AND SUBSIDIARIES</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>(FORMERLY CHAMPIONS SPORTS, INC. AND SUBSIDIARIES)</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>JANUARY 31, 2008 AND 2007 (UNAUDITED)</b></font></p align="center">
</td>
</tr>
</table></div>
<p>
<br><br><br><font size="2"><b>NOTE 2 -&nbsp;<u>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</u></b></font><br><br><font size="2"><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Principles of Consolidation</u></b></font><br><br><font size="2">The condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All material intercompany  transactions have been eliminated in consolidation. </font><br><br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>Goodwill and Other Intangible Assets</u></b></font><br><br><font size="2">In June 2001, the Financial Accounting Standards Board ("FASB") issued Statement No. 142 "Goodwill and Other Intangible Assets". This  statement addresses financial accounting and reporting for acquired goodwill and other intangible assets and supersedes APB Opinion No. 17,  "Intangible Assets". It addresses how intangible assets that are acquired individually or with a group of other assets (but not those acquired in a  business combination)
 should be accounted for in financial statements upon their acquisition.  This Statement also addresses how goodwill and  other intangible assets should be accounted for after they have been initially recognized in the financial statements. </font><br><br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>Intangible Assets</u></b></font><br><br><font size="2">Intangible assets represent costs incurred for patent applications. The costs incurred were valued at the fair value of the stock at the time of  issuance.  The Company will establish its estimated useful life upon approval of the application, which will begin the period of amortization of its  cost.  The Company will estimate the fair value of this asset annually. </font><br><br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>Accounting for Acquisition</u></b></font><br><br><font size="2">The Company has accounted for its acquisition under the purchase method of accounting for business combinations. Under the purchase method 
 of accounting, the cost, including transaction costs, are allocated to the underlying net assets, based on their respective estimated fair values. The  excess of the purchase price over the estimated fair values of the net assets acquired is recorded as goodwill.</font><br><br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>Impairment of Goodwill and Other Intangible Assets</u></b></font><br><br><font size="2">Goodwill and other intangible assets are tested annually for impairment and are tested for impairment more frequently if events and  circumstances indicate that the asset might be impaired.  An impairment loss is recognized to the extent that the carrying amount exceeds the  asset&#8217;s fair value. The Company assesses the recoverability of its goodwill and other intangible assets by comparing the projected undiscounted  net cash flows associated with the related asset, over the remaining lives, in comparison to their respective carrying amounts. Impairment, if any,  is based on the e
xcess of the carrying amount over the fair value of those assets. </font><br><br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font size="2"><b><u>Deferred Revenue</u></b></font><br><br><font size="2">Deferred revenue represents payments received in advance for services to be performed.  When services are rendered, deferred revenue is then recognized as earned.</font><br><br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>Use of Estimates</u></b></font><br><br><font size="2">The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States  of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of  contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the  reporting period.  Actual results could differ from those estimates.    </font><br><br><br></
p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center" style="border-bottom:double">
<font size="2">9</font></p>
</td>
</tr>
</table></div>
<p>
<br></p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>CHAMPIONS BIOTECHNOLOGY, INC. AND SUBSIDIARIES</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>(FORMERLY CHAMPIONS SPORTS, INC. AND SUBSIDIARIES)</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>JANUARY 31, 2008 AND 2007 (UNAUDITED)</b></font></p align="center">
</td>
</tr>
</table></div>
<p>
<br><br><br><font size="2"><b>NOTE 2 -&nbsp;<u>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</u></b>  <b>(CONTINUED)</b></font><br><br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>Net Loss Per Share</u></b></font><br><br><font size="2">Historical net loss per common share is computed using the weighted average number of common shares outstanding. Diluted earnings per share  (EPS) include additional dilution from common stock equivalents, such as stock issuable pursuant to the exercise of stock options and warrants.  Common stock equivalents were not included in the computation of diluted earnings per share for the nine months ended January 31, 2007 when  the Company reported a loss because to do so would have been antidilutive.  </font><br><br><font size="2">The following is a reconciliation of the computation for basic and diluted EPS:</font><br></p>
<div style="position:relative; left: 34"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="71.999982" colspan="1" rowspan="1" bgcolor=#99CCFF>
<p>
<font size="2">&nbsp;</font></p>
</td>
<td width="131.999967" colspan="1" rowspan="1" bgcolor=#99CCFF>
<p>
<font size="2">&nbsp;</font></p>
</td>
<td width="10.666664" colspan="1" rowspan="1" bgcolor=#99CCFF>
<p>
<font size="2">&nbsp;</font></p>
</td>
<td width="35.999991" colspan="1" rowspan="1" bgcolor=#99CCFF>
<p>
<font size="2">&nbsp;</font></p>
</td>
<td width="43.999989" colspan="1" rowspan="1" bgcolor=#99CCFF>
<p>
<font size="2">&nbsp;</font></p>
</td>
<td width="110.666639" colspan="2" rowspan="1" bgcolor=#99CCFF>
<p align="center">
<font size="2"><b>(Restated)</b></font></p align="center">
</td>
<td width="21.333328" colspan="1" rowspan="1" bgcolor=#99CCFF>
&nbsp;</td>
<td width="101.333308" colspan="2" rowspan="1" bgcolor=#99CCFF>
&nbsp;</td>
</tr>
<tr valign="top">
<td width="71.999982" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="131.999967" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="10.666664" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="35.999991" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="43.999989" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="110.666639" colspan="2" rowspan="1" >
<p align="center">
<font size="2"><b>January 31,</b></font></p align="center">
</td>
<td width="21.333328" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="101.333308" colspan="2" rowspan="1" >
<p align="center">
<font size="2"><b>January 31,</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="71.999982" colspan="1" rowspan="1" bgcolor=#99CCFF>
<p>
<font size="2">&nbsp;</font></p>
</td>
<td width="131.999967" colspan="1" rowspan="1" bgcolor=#99CCFF>
<p>
<font size="2">&nbsp;</font></p>
</td>
<td width="10.666664" colspan="1" rowspan="1" bgcolor=#99CCFF>
<p>
<font size="2">&nbsp;</font></p>
</td>
<td width="35.999991" colspan="1" rowspan="1" bgcolor=#99CCFF>
<p>
<font size="2">&nbsp;</font></p>
</td>
<td width="43.999989" colspan="1" rowspan="1" bgcolor=#99CCFF>
<p>
<font size="2">&nbsp;</font></p>
</td>
<td width="110.666639" colspan="2" rowspan="1" bgcolor=#99CCFF>
<p align="center">
<font size="2"><b>2008</b></font></p align="center">
</td>
<td width="21.333328" colspan="1" rowspan="1" bgcolor=#99CCFF>
&nbsp;</td>
<td width="101.333308" colspan="2" rowspan="1" bgcolor=#99CCFF>
<p align="center">
<font size="2"><b>2007</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="71.999982" colspan="1" rowspan="1" >
<p>
<font size="2">&nbsp;</font></p>
</td>
<td width="131.999967" colspan="1" rowspan="1" >
<p>
<font size="2">&nbsp;</font></p>
</td>
<td width="10.666664" colspan="1" rowspan="1" >
<p>
<font size="2">&nbsp;</font></p>
</td>
<td width="35.999991" colspan="1" rowspan="1" >
<p>
<font size="2">&nbsp;</font></p>
</td>
<td width="43.999989" colspan="1" rowspan="1" >
<p>
<font size="2">&nbsp;</font></p>
</td>
<td width="110.666639" colspan="2" rowspan="1" >
<p align="right">
<font size="2">&nbsp;</font></p align="right">
</td>
<td width="21.333328" colspan="1" rowspan="1" >
<p align="right">
<font size="2">&nbsp;</font></p align="right">
</td>
<td width="101.333308" colspan="2" rowspan="1" >
<p align="right">
<font size="2">&nbsp;</font></p align="right">
</td>
</tr>
<tr valign="top">
<td width="203.999949" colspan="2" rowspan="1" bgcolor=#99CCFF>
<p>
<font size="2">Net income (loss)</font></p>
</td>
<td width="10.666664" colspan="1" rowspan="1" bgcolor=#99CCFF>
<p>
<font size="2">&nbsp;</font></p>
</td>
<td width="35.999991" colspan="1" rowspan="1" bgcolor=#99CCFF>
<p>
<font size="2">&nbsp;</font></p>
</td>
<td width="43.999989" colspan="1" rowspan="1" bgcolor=#99CCFF>
<p>
<font size="2">&nbsp;</font></p>
</td>
<td width="21.333328" colspan="1" rowspan="1" bgcolor=#99CCFF>
<p align="right">
<font size="2">$</font></p align="right">
</td>
<td width="87.999978" colspan="1" rowspan="1" bgcolor=#99CCFF>
<p align="right">
<font size="2">174,011&nbsp;</font></p align="right">
</td>
<td width="21.333328" colspan="1" rowspan="1" bgcolor=#99CCFF>
<p align="right">
<font size="2">&nbsp;</font></p align="right">
</td>
<td width="15.999996" colspan="1" rowspan="1" bgcolor=#99CCFF>
<p align="right">
<font size="2">$</font></p align="right">
</td>
<td width="83.999979" colspan="1" rowspan="1" bgcolor=#99CCFF>
<p align="right">
<font size="2"> (74,086)</font></p align="right">
</td>
</tr>
<tr valign="top">
<td width="71.999982" colspan="1" rowspan="1" >
<p>
<font size="2">&nbsp;</font></p>
</td>
<td width="131.999967" colspan="1" rowspan="1" >
<p>
<font size="2">&nbsp;</font></p>
</td>
<td width="10.666664" colspan="1" rowspan="1" >
<p>
<font size="2">&nbsp;</font></p>
</td>
<td width="35.999991" colspan="1" rowspan="1" >
<p>
<font size="2">&nbsp;</font></p>
</td>
<td width="43.999989" colspan="1" rowspan="1" >
<p>
<font size="2">&nbsp;</font></p>
</td>
<td width="110.666639" colspan="2" rowspan="1" >
<p align="right">
<font size="2">&nbsp;</font></p align="right">
</td>
<td width="21.333328" colspan="1" rowspan="1" >
<p align="right">
<font size="2">&nbsp;</font></p align="right">
</td>
<td width="101.333308" colspan="2" rowspan="1" >
<p align="right">
<font size="2">&nbsp;</font></p align="right">
</td>
</tr>
<tr valign="top">
<td width="215.999946" colspan="3" rowspan="1" bgcolor=#99CCFF>
<p>
<font size="2">Weighted-average common shares</font></p>
</td>
<td width="35.999991" colspan="1" rowspan="1" bgcolor=#99CCFF>
<p>
<font size="2">&nbsp;</font></p>
</td>
<td width="43.999989" colspan="1" rowspan="1" bgcolor=#99CCFF>
<p>
<font size="2">&nbsp;</font></p>
</td>
<td width="110.666639" colspan="2" rowspan="1" bgcolor=#99CCFF>
<p align="right">
<font size="2">&nbsp;</font></p align="right">
</td>
<td width="21.333328" colspan="1" rowspan="1" bgcolor=#99CCFF>
<p align="right">
<font size="2">&nbsp;</font></p align="right">
</td>
<td width="101.333308" colspan="2" rowspan="1" bgcolor=#99CCFF>
<p align="right">
<font size="2">&nbsp;</font></p align="right">
</td>
</tr>
<tr valign="top">
<td width="203.999949" colspan="2" rowspan="1" >
<p>
<font size="2">outstanding (basic)</font></p>
</td>
<td width="10.666664" colspan="1" rowspan="1" >
<p>
<font size="2">&nbsp;</font></p>
</td>
<td width="35.999991" colspan="1" rowspan="1" >
<p>
<font size="2">&nbsp;</font></p>
</td>
<td width="43.999989" colspan="1" rowspan="1" >
<p>
<font size="2">&nbsp;</font></p>
</td>
<td width="110.666639" colspan="2" rowspan="1" >
<p align="right">
<font size="2">31,386,454&nbsp;</font></p align="right">
</td>
<td width="21.333328" colspan="1" rowspan="1" >
<p align="right">
<font size="2">&nbsp;</font></p align="right">
</td>
<td width="101.333308" colspan="2" rowspan="1" >
<p align="right">
<font size="2">20,489,493&nbsp;</font></p align="right">
</td>
</tr>
<tr valign="top">
<td width="203.999949" colspan="2" rowspan="1" bgcolor=#99CCFF>
&nbsp;</td>
<td width="10.666664" colspan="1" rowspan="1" bgcolor=#99CCFF>
&nbsp;</td>
<td width="35.999991" colspan="1" rowspan="1" bgcolor=#99CCFF>
&nbsp;</td>
<td width="43.999989" colspan="1" rowspan="1" bgcolor=#99CCFF>
&nbsp;</td>
<td width="110.666639" colspan="2" rowspan="1" bgcolor=#99CCFF>
&nbsp;</td>
<td width="21.333328" colspan="1" rowspan="1" bgcolor=#99CCFF>
&nbsp;</td>
<td width="101.333308" colspan="2" rowspan="1" bgcolor=#99CCFF>
&nbsp;</td>
</tr>
<tr valign="top">
<td width="203.999949" colspan="2" rowspan="1" >
<p>
<font size="2">Weighted-average common stock equivalents</font></p>
</td>
<td width="10.666664" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="35.999991" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="43.999989" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="110.666639" colspan="2" rowspan="1" >
&nbsp;</td>
<td width="21.333328" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="101.333308" colspan="2" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="203.999949" colspan="2" rowspan="1" bgcolor=#99CCFF>
<p>
<font size="2">&nbsp;&nbsp;Stock options</font></p>
</td>
<td width="10.666664" colspan="1" rowspan="1" bgcolor=#99CCFF>
&nbsp;</td>
<td width="35.999991" colspan="1" rowspan="1" bgcolor=#99CCFF>
&nbsp;</td>
<td width="43.999989" colspan="1" rowspan="1" bgcolor=#99CCFF>
&nbsp;</td>
<td width="110.666639" colspan="2" rowspan="1" bgcolor=#99CCFF>
<p align="right">
<font size="2">439,835</font></p align="right">
</td>
<td width="21.333328" colspan="1" rowspan="1" bgcolor=#99CCFF>
&nbsp;</td>
<td width="101.333308" colspan="2" rowspan="1" bgcolor=#99CCFF>
<p align="right">
<font size="2">-</font></p align="right">
</td>
</tr>
<tr valign="top">
<td width="203.999949" colspan="2" rowspan="1" >
<p>
<font size="2">&nbsp;&nbsp;Warrants</font></p>
</td>
<td width="10.666664" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="35.999991" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="43.999989" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="110.666639" colspan="2" rowspan="1" >
<p align="right">
<font size="2">642,055</font></p align="right">
</td>
<td width="21.333328" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="101.333308" colspan="2" rowspan="1" >
<p align="right">
<font size="2">-  </font></p align="right">
</td>
</tr>
<tr valign="top">
<td width="71.999982" colspan="1" rowspan="1" bgcolor=#99CCFF>
&nbsp;</td>
<td width="131.999967" colspan="1" rowspan="1" bgcolor=#99CCFF>
&nbsp;</td>
<td width="10.666664" colspan="1" rowspan="1" bgcolor=#99CCFF>
&nbsp;</td>
<td width="35.999991" colspan="1" rowspan="1" bgcolor=#99CCFF>
&nbsp;</td>
<td width="43.999989" colspan="1" rowspan="1" bgcolor=#99CCFF>
&nbsp;</td>
<td width="110.666639" colspan="2" rowspan="1" bgcolor=#99CCFF>
&nbsp;</td>
<td width="21.333328" colspan="1" rowspan="1" bgcolor=#99CCFF>
&nbsp;</td>
<td width="101.333308" colspan="2" rowspan="1" bgcolor=#99CCFF>
&nbsp;</td>
</tr>
<tr valign="top">
<td width="203.999949" colspan="2" rowspan="1" >
<p>
<font size="2">Weighted-average common</font></p>
</td>
<td width="10.666664" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="35.999991" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="43.999989" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="110.666639" colspan="2" rowspan="1" >
&nbsp;</td>
<td width="21.333328" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="101.333308" colspan="2" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="203.999949" colspan="2" rowspan="1" bgcolor=#99CCFF>
<p>
<font size="2">shares outstanding (diluted)</font></p>
</td>
<td width="10.666664" colspan="1" rowspan="1" bgcolor=#99CCFF>
&nbsp;</td>
<td width="35.999991" colspan="1" rowspan="1" bgcolor=#99CCFF>
&nbsp;</td>
<td width="43.999989" colspan="1" rowspan="1" bgcolor=#99CCFF>
&nbsp;</td>
<td width="110.666639" colspan="2" rowspan="1" bgcolor=#99CCFF>
<p align="right">
<font size="2">32,468,344</font></p align="right">
</td>
<td width="21.333328" colspan="1" rowspan="1" bgcolor=#99CCFF>
&nbsp;</td>
<td width="101.333308" colspan="2" rowspan="1" bgcolor=#99CCFF>
<p align="right">
<font size="2">20,489,493</font></p align="right">
</td>
</tr>
</table></div>
<p>
<br><br></p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center" style="border-bottom:double">
<font size="2">10</font></p>
</td>
</tr>
</table></div>
<p>
<br></p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>CHAMPIONS BIOTECHNOLOGY, INC. AND SUBSIDIARIES</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>(FORMERLY CHAMPIONS SPORTS, INC. AND SUBSIDIARIES)</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>JANUARY 31, 2008 AND 2007 (UNAUDITED)</b></font></p align="center">
</td>
</tr>
</table></div>
<p>
<br><br><br><font size="2"><b>NOTE 2 - <u>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</u></b>  <b>(CONTINUED)</b></font><br><br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>Cash and Cash Equivalents</u></b></font><br><br><font size="2">For purposes of the condensed consolidated statements of cash flow, the Company considers all highly liquid debt instruments purchased with a  maturity of three months or less, unless restricted as to use, to be cash equivalents. At various times throughout the years the Company had  amounts on deposit at financial institutions in excess of federally insured limits.</font><br><br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>Income Taxes</u></b></font><br><br><font size="2">The Company has adopted the provisions of Statement of Financial Accounting Standards No. 109 (the Statement), Accounting for Income  Taxes. The Statement requires an asset and liability approach for financial accounting and reporting for income taxes, and the recognition o
f  deferred tax assets and liabilities for the temporary differences between the financial reporting bases and tax bases of the Company&#8217;s assets and  liabilities at enacted tax rates expected to be in effect when such amounts are realized or settled.</font><br><br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>Fair Value of Financial Instruments</u></b></font><br><br><font size="2">The carrying amounts of the Company&#8217;s financial instruments, including cash and cash equivalents, accounts payable, and accrued expenses,  officer loans payable approximate fair values because of the short maturities of these instruments.</font><br><br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>Stock-Based Compensation</u></b></font><br><br><font size="2">Employee stock awards under the Company&#8217;s compensation plans are accounted for in accordance with Statement of Financial Accounting  Standards No. 123 (Revised 2004), "<i>Share-Based Payment</i>" ("SFAS 123R").  SFAS 123R requ
ires that compensation cost related to share-based  payment transactions be recognized in the financial statements. Share-based payment transactions within the scope of SFAS 123R include stock  options, restricted stock plans, performance-based awards, stock appreciation rights, and employee share purchase plans.  The provisions of  SFAS 123R, as amended, are effective for small business issuers beginning as of the next fiscal year after December&nbsp;15, 2005.  Accordingly, the  Company implemented the revised standard in the first quarter of fiscal year 2007. </font><br><br><br></p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center" style="border-bottom:double">
<font size="2">11</font></p>
</td>
</tr>
</table></div>
<p>
<br></p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>CHAMPIONS BIOTECHNOLOGY, INC. AND SUBSIDIARIES</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>(FORMERLY CHAMPIONS SPORTS, INC. AND SUBSIDIARIES)</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>JANUARY 31, 2008 AND 2007 (UNAUDITED)</b></font></p align="center">
</td>
</tr>
</table></div>
<p>
<br><br><br><font size="2"><b>NOTE 2 - <u>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</u></b>  <b>(CONTINUED)</b></font><br><br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>Stock-Based Compensation</u> (Continued)</b></font><br><br><font size="2">The Company measures compensation expense for its non-employee stock-based compensation under the Financial Accounting Standards Board  (FASB) Emerging Issues Task Force (EITF) Issue No. 96-18, "<i>Accounting for Equity Instruments that are Issued to Other Than Employees for  Acquiring, or in Conjunction with Selling, Goods or Services</i>". The fair value of the option issued is used to measure the transaction, as this is  more reliable than the fair value of the services received. The fair value is measured at the value of the Company&#8217;s common stock on the date that  the commitment for performance by the counterparty has been reached or the counterparty&#8217;s performance is complete. The fair value of the equity instrument is charged direc
tly to compensation expense and additional paid-in capital.</font><br><br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>Recent Accounting Pronouncements</u></b></font><br><br><font size="2">In May&nbsp;2005, the FASB issued SFAS No.&nbsp;154, "Accounting Changes and Error Corrections." SFAS No.&nbsp;154 replaces Accounting Principles  Board ("APB") Opinion No.&nbsp;20, "Accounting Changes" and SFAS No.&nbsp;3, "Reporting Accounting Changes in Interim Financial Statements."  SFAS No.&nbsp;154 requires retrospective application to prior periods&#8217; financial statements of a voluntary change in accounting principle unless it is  impracticable. APB No.&nbsp;20 previously required that most voluntary changes in accounting principle be recognized by including the cumulative  effect of changing to the new accounting principle in net income in the period of the change. SFAS No.&nbsp;154 is effective for accounting changes  and corrections of errors made in fiscal years beginning after December&nb
sp;15, 2005. The adoption of SFAS No.&nbsp;154 did not have a material impact  on the Company&#8217;s financial position, results of operations, or cash flows.</font><br><br><font size="2">In February&nbsp;2006, the FASB issued SFAS No.&nbsp;155, "Accounting for Certain Hybrid Financial Instruments, an amendment of FASB Statements  No.&nbsp;133 and 140." SFAS No.&nbsp;155 resolves issues addressed in SFAS No.&nbsp;133 Implementation Issue No.&nbsp;D1, "Application of Statement 133 to  Beneficial Interests in Securitized Financial Assets," and permits fair value remeasurement for any hybrid financial instrument that contains an  embedded derivative that otherwise would require bifurcation, clarifies which interest-only strips and principal-only strips are not subject to the  requirements of SFAS No.&nbsp;133, establishes a requirement to evaluate interests in securitized financial assets to identify interests that are  freestanding derivatives or that are hybrid financial instruments that contain an embedded 
derivative requiring bifurcation, clarifies that  concentrations of credit risk in the form of subordination are not embedded derivatives and amends SFAS No.&nbsp;140 to eliminate the prohibition on  a qualifying special-purpose entity from holding a derivative financial instrument that pertains to a beneficial interest other than another  derivative financial instrument. SFAS No.&nbsp;155 is effective for all financial instruments acquired or issued after the beginning of the first fiscal  year that begins after September&nbsp;15, 2006. The adoption of FAS 155 did not have a material impact on the Company&#8217;s financial position, results  of operations, or cash flows.</font><br><br><br></p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center" style="border-bottom:double">
<font size="2">12</font></p>
</td>
</tr>
</table></div>
<p>
<br></p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>CHAMPIONS BIOTECHNOLOGY, INC. AND SUBSIDIARIES</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>(FORMERLY CHAMPIONS SPORTS, INC. AND SUBSIDIARIES)</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>JANUARY 31, 2008 AND 2007 (UNAUDITED)</b></font></p align="center">
</td>
</tr>
</table></div>
<p>
<br><br><br><font size="2"><b>NOTE 2 - <u>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES </u>(CONTINUED)</b></font><br><br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>Recent Accounting Pronouncements</u></b> <b>(Continued)</b></font><br><br><font size="2">In March&nbsp;2006, the FASB issued SFAS No.&nbsp;156, "Accounting for Servicing of Financial Assets, an amendment of FASB Statement No.&nbsp;140."  SFAS No.&nbsp;156 requires an entity to recognize a servicing asset or liability each time it undertakes an obligation to service a financial asset by  entering into a servicing contract under a transfer of the servicer&#8217;s financial assets that meets the requirements for sale accounting, a transfer of  the servicer&#8217;s financial assets to a qualified special-purpose entity in a  guaranteed mortgage securitization in which the transferor retains all of  the resulting securities and classifies them as either available-for-sale or trading securities in accordance with SFAS No.&nbsp;115, "Ac
counting for  Certain Investments in Debt and Equity Securities" and an acquisition or assumption of an obligation to service a financial asset that does not  relate to financial assets of the servicer or its consolidated affiliates.<b> </b></font><br><br><font size="2">Additionally, SFAS No.&nbsp;156 requires all separately recognized servicing assets and servicing liabilities to be initially measured at fair value,  permits an entity to choose either the use of an amortization or fair value method for subsequent measurements, permits at initial adoption a one- time reclassification of available-for-sale securities to trading securities by entities with recognized servicing rights and requires separate  presentation of servicing assets and liabilities subsequently measured at fair value and additional disclosures for all separately recognized  servicing assets and liabilities. SFAS No.&nbsp;156 is effective for transactions entered into after the beginning of the first fiscal year that begins after  Septemb
er&nbsp;15, 2006. The adoption of FAS 156 did not have a material impact on the Company&#8217;s financial position or results of operations.</font><br><br><font size="2">In September 2006, The Financial Accounting Standards Board ("FASB") issued Statement of Financial Accounting Standards ("SFAS") No.  157, "Fair Value Measurement" ("SFAS No. 157"). This standard provides guidance for using fair value to measure assets and liabilities. SFAS  No. 157 applies whenever other standards require (or permit) assets or liabilities to be measured at fair value but does not expand the use of fair  value in any new circumstances. Prior to SFAS No. 157, the methods for measuring fair value were diverse and inconsistent, especially for items  that are not actively traded. The standard clarifies that for items that are not actively traded, such as certain kinds of derivatives, fair value should  reflect the price in a transaction with a market participant, including an adjustment for risk, not just the company&#8217;s mar
k-to-model value. SFAS  No. 157 also requires expanded disclosure of the effect on earnings for items measured using unobservable data. SFAS No. 157 is effective for  financial statements issued for fiscal years beginning after November 15, 2007, and interim periods within those fiscal years. The Company is  currently evaluating the impact of this statement on its financial statements and expects to adopt SFAS No.157 January 31, 2008.</font><br><br><br></p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center" style="border-bottom:double">
<font size="2">13</font></p>
</td>
</tr>
</table></div>
<p>
<br></p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>CHAMPIONS BIOTECHNOLOGY, INC. AND SUBSIDIARIES</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>(FORMERLY CHAMPIONS SPORTS, INC. AND SUBSIDIARIES)</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>JANUARY 31, 2008 AND 2007 (UNAUDITED)</b></font></p align="center">
</td>
</tr>
</table></div>
<p>
<br><br><br><font size="2"><b>NOTE 2 - <u>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES </u>(CONTINUED)</b></font><br><br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>Recent Accounting Pronouncements</u></b> <b>(Continued)</b></font><br><br><font size="2">In September 2006, the FASB issued SFAS No. 158, "Employers&#8217; Accounting for Defined Benefit Pension and Other Postretirement Plans -- An  Amendment of FASB Statements No. 87, 88, 106, and 132R."  This standard requires an employer to: (a) recognize in its statement of financial  position an asset for a plan&#8217;s overfunded status or a liability for a plan&#8217;s underfunded status; (b) measure a plan&#8217;s assets and its obligations that  determine its funded status as of the end of the employer&#8217;s fiscal year (with limited exceptions); and (c) recognize changes in the funded status of  a defined benefit postretirement plan in the year in which the changes occur. Those changes will be reported in comprehensive income. The  re
quirement to recognize the funded status of a benefit plan and the disclosure requirements are effective as of the end of the fiscal year ending  after December 15, 2006. The requirement to measure plan assets and benefit obligations as of the date of the employer&#8217;s fiscal year-end  statement of financial position is effective for fiscal years ending after December 15, 2008. The Company is evaluating the impact of this  statement on its financial statements and believes that such impact may be material.</font><br><br><font size="2">In February 2007, the FASB issued SFAS No. 159, &#8220;The Fair Value Option for Financial Assets and Liabilities, including an amendment of  FASB Statement No. 115&#8221; (&#8220;SFAS No. 159&#8221;). SFAS No. 159 permits entities to choose, at specified election dates, to measure many financial  instruments and certain other items at fair value that are not currently required to be measured at fair value. Unrealized gains and losses shall be  reported on items for which th
e fair value option has been elected in earnings at each subsequent reporting date. SFAS No. 159 is effective for  fiscal years beginning after November 15, 2007. Early adoption is permitted as of the beginning of a fiscal year that begins on or before  November 15, 2007, provided the entity also elects to apply the provisions of SFAS No. 157 &#8220;Fair Value Measurements&#8221; (&#8220;SFAS No. 157&#8221;). The  Company is currently assessing the impact that SFAS No. 159 will have on its financial statements.</font><br><br><font size="2"><b>NOTE 3 <u>OTHER ACCRUED EXPENSES</u></b></font><br><br><font size="2">This account represents accrued officer&#8217;s payroll and related payroll taxes. </font><br><br><br><font size="2"><b>NOTE 4 - <u>OFFICER LOANS PAYABLE</u></b></font><br><br><font size="2">For the nine months ended January 31, 2007, the Company received working capital advances from an officer of the Company which were repaid  during the nine months ended January 31, 2008 without interest.  </font><
br><br><br></p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center" style="border-bottom:double">
<font size="2">14</font></p>
</td>
</tr>
</table></div>
<p>
<br></p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>CHAMPIONS BIOTECHNOLOGY, INC. AND SUBSIDIARIES</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>(FORMERLY CHAMPIONS SPORTS, INC. AND SUBSIDIARIES)</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>JANUARY 31, 2008 AND 2007 (UNAUDITED)</b></font></p align="center">
</td>
</tr>
</table></div>
<p>
<br><br><font size="2"><b>NOTE 5 - <u>STOCKHOLDERS&#8217; EQUITY</u> </b></font><br><br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>Common Stock</u> </b></font><br><br><font size="2">The Company has 50,000,000 shares authorized and 31,794,146 shares issued and outstanding at January 31, 2008.</font><br><br><font size="2">On May 18, 2007, the Company entered into an Agreement and Plan of Merger with Biomerk, Inc., a privately owned company, whereby the  Company issued 4,000,000 restricted shares of its common stock to acquire 100% of the outstanding stock of Biomerk, Inc.</font><br><br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>Stock Options</u></b></font><br><br><font size="2">On January 15, 2007, the Company entered into various agreements with consultants to issue three hundred and forty thousand options,  exercisable over a five year period based on a fair value exercise price on the date of issuance ($0.17) exercisable expiring through January 15,  2012 for services
 to be rendered.  The options vested on January 15, 2008 and have been valued at $44,184 using the Black-Scholes Model with  an annualized volatility rate of 100% and a bond interest rate of 4.43%.  Amortization expense for services rendered was $33,138 for the nine  months ended January 31, 2008.  On May 15, 2007, the Company entered into a consulting agreement to issue five hundred thousand options,  exercisable over a five-year period based on a fair value exercise price on the date of issuance ($0.30) exercisable expiring through May 15, 2012  for services to be rendered over three years.  The options vest as follows:  166,665 upon the first anniversary of the grant date, 166,665 upon the  second anniversary of the grant date and 166,670 upon the third anniversary of the grant date and have been valued at $149,974 using the Black- Scholes Model with an annualized volatility rate of 270% and a bond interest rate of 4.35%.  Amortization expense for services rendered was  $35,745 for the nine months ended J
anuary 31, 2008. On May 15, 2007, the Company entered into a consulting agreement to issue twenty- five  thousand options, exercisable over a five-year period based on a fair value exercise price on the date of issuance ($0.30) exercisable expiring  through May 15, 2012 for services to be rendered over one year.  The options vest on May 15, 2008 and have been valued at $7,499 using the  Black-Scholes Model with an annualized volatility rate of 270% and a bond interest rate of 4.35%.  Amortization expense for services rendered  was $5,364 for the nine months ended January 31, 2008.   On October 10, 2007, the Company entered into a consulting agreement to issue five  hundred thousand options, exercisable over a five-year period based on a fair value exercise price on the date of issuance ($0.75) exercisable  expiring through October 10, 2012 for services to be rendered over three years.  The options vest as follows:  166,665 upon the first anniversary  of the grant date, 166,665 upon the second anniversary of 
the grant date and 166,670 upon the third anniversary of the grant date and have been  valued at $336,287 using the Black-Scholes Model with an annualized volatility rate of 141% and a bond interest rate of 4.38%.  Amortization  expense for services rendered was $34,703 for the nine months ended January 31, 2008.</font><br><br><br></p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center" style="border-bottom:double">
<font size="2">15</font></p>
</td>
</tr>
</table></div>
<p>
<br></p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>CHAMPIONS BIOTECHNOLOGY, INC. AND SUBSIDIARIES</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>(FORMERLY CHAMPIONS SPORTS, INC. AND SUBSIDIARIES)</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>JANUARY 31, 2008 AND 2007 (UNAUDITED)</b></font></p align="center">
</td>
</tr>
</table></div>
<p>
<br><br><br><font size="2"><b>NOTE 6 - <u>GOING CONCERN</u></b></font><br><br><font size="2">As shown in the accompanying condensed consolidated financial statements, the Company has sustained net operating losses for the years ended  April 30, 2007 and 2006 and has sustained large accumulated deficits that raise substantial doubt about its ability to continue as a going concern.</font><br><br><font size="2">The Company&#8217;s future success is dependent upon its ability to achieve profitable operations and generate cash from operating activities, and upon additional financing. There is no guarantee that the Company will be able to raise enough capital or generate revenues to sustain its operations. The Company&#8217;s operations are generating revenues through its services and the Company is attempting to secure financing for future growth initiatives. </font><br><br><font size="2">The condensed consolidated financial statements do not include any adjustments that might result from the outcome of this unce
rtainty.</font><br><br><br><font size="2"><b>NOTE 7 - <u>PROVISION FOR INCOME TAXES</u></b></font><br><br><font size="2">Deferred income taxes will be determined using the liability method for the temporary differences between the financial reporting basis and  income tax basis of the Company&#8217;s assets and liabilities. Deferred income taxes will be measured based on the tax rates expected to be in effect  when the temporary differences are included in the Company&#8217;s consolidated tax return. Deferred tax assets and liabilities are recognized based on  anticipated future tax consequences attributable to differences between financial statement carrying amounts of assets and liabilities and their  respective tax bases.</font><br><br><font size="2">At January 31, 2008 and 2007, deferred tax assets consist of the following: </font><br></p>
<div style="position:relative; left: 0"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="257.333269" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="89.333311" colspan="2" rowspan="1" >
<p align="center">
<font size="2">(Restated)</font></p align="center">
</td>
<td width="11.999997" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="89.333311" colspan="2" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="257.333269" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="89.333311" colspan="2" rowspan="1" >
<p align="center" style="border-bottom:solid windowtext .5pt">
<font size="2">2008</font></p>
</td>
<td width="11.999997" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="89.333311" colspan="2" rowspan="1" >
<p align="center" style="border-bottom:solid windowtext .5pt">
<font size="2">2007</font></p>
</td>
</tr>
<tr valign="top">
<td width="257.333269" colspan="1" rowspan="1" >
<p>
<font size="2">Deferred tax asset </font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
<p>
<font size="2">$</font></p>
</td>
<td width="71.999982" colspan="1" rowspan="1" >
<p align="right">
<font size="2">2,425,582&nbsp;</font></p align="right">
</td>
<td width="11.999997" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
<p>
<font size="2">$</font></p>
</td>
<td width="71.999982" colspan="1" rowspan="1" >
<p align="right">
<font size="2">2,452,896&nbsp;</font></p align="right">
</td>
</tr>
<tr valign="top">
<td width="257.333269" colspan="1" rowspan="1" >
<p>
<font size="2">Less:  valuation allowance           </font></p>
</td>
<td width="89.333311" colspan="2" rowspan="1" >
<p align="right">
<font size="2">(2,425,582)</font></p align="right">
</td>
<td width="11.999997" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="89.333311" colspan="2" rowspan="1" >
<p align="right">
<font size="2">(2,452,896)</font></p align="right">
</td>
</tr>
<tr valign="top">
<td width="257.333269" colspan="1" rowspan="1" >
<p>
<font size="2">Net deferred tax asset</font></p>
</td>
<td width="17.333329" colspan="1" rowspan="1" >
<p>
<font size="2">$</font></p>
</td>
<td width="71.999982" colspan="1" rowspan="1" >
<p align="right">
<font size="2">-0-&nbsp;</font></p align="right">
</td>
<td width="11.999997" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="17.333329" colspan="1" rowspan="1" >
<p>
<font size="2">$</font></p>
</td>
<td width="71.999982" colspan="1" rowspan="1" >
<p align="right">
<font size="2">-0-&nbsp;</font></p align="right">
</td>
</tr>
<tr valign="top">
<td width="449.333221" colspan="6" rowspan="1" >
&nbsp;</td>
</tr>
</table></div>
<p>
<br><font size="2">At January 31, 2008 and 2007, the Company had federal net operating loss carryforwards in the approximate amounts of $6,930,234 and  $7,008,273 available to offset future taxable income. The Company established valuation allowances equal to the full amount of the deferred tax  assets due to the uncertainty of the utilization of the operating losses in future periods. </font><br><br><br><b>NOTE 8 - <u>RESTATEMENT</u></b><br><br><font size="2">The Company has amended its previously issued condensed consolidated financial statements for the three months ended January 31, 2008 to reclassify $300,000 as deferred revenue previously recorded as revenue.  The effect of this change resulted in a reduction of net income for the three months ended January 31, 2008 of $300,000 to net income of $174,011 and an increase in the accumulated deficit to $6,930,234.  This also reduced earnings per share (basis/diluted) from $0.02 to $0.01.</font><br><br><br></p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center" style="border-bottom:double">
<font size="2">16</font></p>
</td>
</tr>
</table></div>
<p>
<br><br><font size="2">Item 2.&nbsp;&nbsp;&nbsp;Management&#8217;s Discussion and Analysis or Plan of Operation</font><br><br><font size="2"><b>SPECIAL NOTE REGARDING FORWARD LOOKING STATEMENTS</b></font><br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>This document contains "forward-looking statements" within the meaning of Section 27A of the Securities Act and Section 21E of  the Securities Exchange Act that inherently involve risk and uncertainties.  The Company generally uses words such as "believe,"  "may," "could," "will," "intend," "estimate," "expect," "anticipate," "plan," "likely," "promise" and similar expressions to identify  forward-looking statements.  One should not place undue reliance on these forward-looking statements.  The Company&#8217;s actual results  could differ materially from those anticipated in the forward-looking statements for many unforeseen factors., which may include, but  are not limited to, changes in general economic conditions, the ongoing threat of terror
ism, ability to have access to financing sources on  reasonable terms and other risks that are identified under "RISK FACTORS" of the Company&#8217;s most recent Form 10-KSB. Although  the Company believes the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the  date on which the statements are made, and the Company&#8217;s future results, levels of activity, performance or achievements may not meet  these expectations.  The Company does not intend to update any of the forward-looking statements after the date of this document to </b></font><br><font size="2"><b>conform these statements to actual results or to changes in the Company&#8217;s expectations, except as required by law. </b></font><br><br><font size="2"><b>Company Overview and Recent Developments</b></font><br><br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Champions Biotechnology, Inc. (referred in this 10-QSB by terms "Company", "we" or "our") is engaged in the development  o
f  advanced preclinical platforms and predictive tumor specific data to enhance and accelerate the value of oncology drugs for companies and  physicians.</font> <font size="2">The Company intends to improve methods and approaches to disease treatment.  Our current plan calls for the development of a  management team, selection and appointment of new members to our Board of Directors, formation of a Scientific Advisory Board and securing  additional funding to accelerate the development of the Company&#8217;s preclinical platform and drug portfolio. </font><br></p>
<p style="margin-left:80"> <font size="2">Our Preclinical Platform is a novel
approach based upon the direct implantation of primary human tumors in immune
deficient mice  and propagation of the resulting xenografts (Biomerk
Tumorgrafts&#8482;) in a manner that preserves the biological characteristics of
the  original human tumor.  Biomerk Tumorgrafts&#8482;, unlike cell line derived
xenografts used in traditional preclinical testing, are never  passaged in cell
tissue culture. The Company believes that these Tumorgrafts more closely reflect
human cancer biology and their  response to drugs is more predictive of clinical
outcomes in cancer patients. The Company has several patent applications
relating to  the use of its preclinical models in identifying potentially active
chemotherapeutic agents. </font></p><p>
<br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We plan to leverage our preclinical platform to evaluate drug candidates and develop a portfolio of novel therapeutic candidates through  pre-clinical trials.  If drugs reach this early stage of development, the Company intends to sell, partner with or license them to pharmaceutical  and/or biotechnology companies, as appropriate. Management believes this strategy will enable the Company to maximize its return on </font><br><font size="2">investment in a relatively short time frame. </font><br></p>
<p>
<font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company also offers
its preclinical platform and predictive tumor data to physicians for
personalized patient care and to companies  for a more predictive evaluation of
oncology drugs in models that integrate drug evaluation with biomarker
discovery.  The Company expanded  its preclinical platform, grew its physician
services and advanced its research collaborations during the quarter.  Recently
the Company entered  into a Master Services Agreement for preclinical evaluation
of oncology drug candidates with one of the world&#8217;s leading pharmaceutical
companies. </font></p>
<p>
<font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In October, 2007, Dr. David Sidransky was appointed the Chairman of the Board of Directors. Dr. Sidransky is a renowned oncologist  and research scientist named and profiled by TIME magazine in 2001 as one of the top physicians and scientists in America, recognized for his  work with early detection of cancer. He is the Director of the Head and Neck Cancer Research Division at Johns Hopkins University School of  Medicine and Professor of Oncology, Otolaryngology, Cellular &amp; Molecular Medicine, Urology, Genetics, and Pathology at John Hopkins  University and Hospital. Dr. Sidransky is one of the most highly cited researchers in clinical and medical journals in the world, in the field of  oncology during the past decade, with over 300 peer-reviewed publications. He has contributed more than 40 cancer reviews and chapters. Dr.  Sidransky is a founder of a number of biotechnology companies and holds numerous biotechnology patents. He has served as Vice
 Chairman of  the Board of Directors, and presently is a director of ImClone. He is the Chairman of Alfacell and serves on the Board of Directors of  Xenomics. He is serving and has served on scientific advisory boards of MedImmune, Roche, Amgen and Veridex, LLC (a Johnson &amp; Johnson  diagnostic company), among others. Dr. Sidransky serves as Director (2005-2008) of American Association for Cancer Research (AACR).   He was the chairperson of AACR International Conferences (2006 and 2007) on Molecular Diagnostics in Cancer Therapeutic Development:  Maximizing Opportunities for Individualized Treatment.  Dr. Sidransky is the recipient of a number of awards and honors, including the 1997  Sarstedt International Prize from the German Society of Clinical Chemistry, the 1998 Alton Ochsner Award Relating Smoking and Health by the  American College of Chest Physicians and the 2004 Hinda and Richard Rosenthal Award from the American Association of Cancer Research.</font><br><br><font size="2">&nbsp;&nbsp;&nbsp;&nb
sp;&nbsp;&nbsp;&nbsp;In May 2007, we acquired Biomerk, Inc., a company focused on generating a novel preclinical platform of human cancer tumor immune- deficient mice xenografts (Biomerk Tumorgrafts&#8482;).  Biomerk Tumorgrafts&#8482;, unlike standard cell line derived xenografts, are implanted directly  from primary human cancer tumors. The Company believes that these xenografts more closely reflect human cancer biology and are more  predictive of clinical outcome.  The Company believes that it as well as biotechnology and  pharmaceutical companies, as part of their drug  discovery and post marketing efforts, may benefit from utilizing the Company&#8217;s preclinical platform that is more predictive and may provide for a faster and less expensive path for drug approval. </font><br><br></p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center" style="border-bottom:double">
<font size="2">17</font></p>
</td>
</tr>
</table></div>
<p>
<br><br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In February 2007, we acquired the patent rights to two Benzoylphenylurea (BPU) sulfur analog compounds that have shown promising  potent activity against in vitro and in vivo models of prostate and pancreatic cancer (Journal of Medicinal Chemistry, 2006, Vol. 49, No.7, 2357- 2360 and American Association for Cancer Research Journal of Molecular Cancer Therapeutics, Vol. 6, Issue 5, May 2007, 1509-16.). The  acquired rights include pending U.S. Patent Application and the corresponding international patent application filed under the Patent Cooperation  Treaty (PCT), both entitled Design and Synthesis of Novel Tubulin Polymerization Inhibitors:  Benzoylphenylurea (BPU) Sulfur Analogs.  </font><br><br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company was incorporated under the laws of the State of Delaware in June 1985 as a small merger and acquisition company under the  name "International Group, Inc.". In September 1985, the C
ompany completed a public offering, and in January 1986, acquired the world-wide  rights to the Champions sports theme restaurant concept and subsequently changed its name to "Champions Sports, Inc." In 1997, the Company  sold its Champions service mark and concept for sports themed restaurants&nbsp;to Marriott International, Inc. and since then until January 2007, had  been seeking a new business direction.  In January 2007, the Company changed its name to Champions Biotechnology, Inc. to reflect the decision  of the Company to focus on biotechnology. </font><br><br><font size="2"><b>Results of Operation</b></font><br><br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For the nine months ended January 31, 2008, the Company&#8217;s net income was $174,011 producing earnings per share of $0.01 and the net  income for the three months ended January 31, 2008 was $311,006 producing earnings per share of $0.01. For the nine months ended January 31,  2007, the Company&#8217;s net loss was $74,086 and the
 net loss for the three months ended January 31, 2007 was $37,198.  In the nine months ended  January 31, 2008, the Company began its operations as a biotechnology company while in the nine months ended January 31, 2007, it had no  operations. The Company acquired Biomerk, Inc. in May 2007. The Company&#8217;s total assets at January 31, 2008 were $1,973,573. The  Company&#8217;s total assets at January 31, 2007 were $20,779.  </font><br><br><font size="2"><b>Revenues</b></font><br><br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company&#8217;s total operating revenues were $874,940 for the nine months ended January 31, 2008 and $624,940 for the three months  ended January 31, 2008. The Company generated revenues for the nine months ended January 31, 2008 for providing oncology services.</font><br><br><font size="2"><b>Expenses</b></font><br><br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For the nine months ended January 31, 2008, expenses were $716,986 and $319,998 for the thr
ee months ended January 31, 2008 compared   to $74,086 for the nine months ended January 31, 2007 and $37,198 for the three months ended January 31, 2007. The increased expenses  represented the Company moving forward in executing its new business plan of building a biotechnology company. For the nine months ended  January 31, 2008, service expenses were $264,262 and general and administrative expenses were $377,724.  For the three months ended  January&nbsp;31, 2008, service expenses were $201,222 and general and administrative expenses were $118,776. The service expenses were due to  significant increase in the Company&#8217;s operating activities providing oncology services for administrating expert medical information panels and  for preclinical services. The increase in general and administrative expenses was due to increase in professional legal and accounting fees relating  to the acquisition of Biomerk, Inc., fees associated with maintaining the Company&#8217;s patent position and stock option based 
amortized  compensation.  For the nine months ended January 31, 2007, the expenses of $74,086 were associated with the maintenance of the Company as it </font><br><font size="2">was seeking a new business direction.</font><br><br><br></p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center" style="border-bottom:double">
<font size="2">18</font></p>
</td>
</tr>
</table></div>
<p>
<br><font size="2"><b>Liquidity and Capital Resources</b></font><br><br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company&#8217;s cash position as of January 31, 2008 was $1,072,453, compared to $3,758 on April 30, 2007. For the nine month period  ended January 31, 2008, the Company&#8217;s operations provided $612,506.</font><br><br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company&#8217;s working capital was $356,747 at January 31, 2008 versus a deficit of $441,065 at April 30, 2007.  This increase in  working capital was due to the operations of the Company during the nine months ended January 31, 2008 after the acquisition, on May  18, 2007, of Biomerk, Inc., a private company.  </font><br><br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company anticipates that the revenues generated for the nine months ended January 31, 2008 and the Biomerk acquisition, which  provided the Company with approximately $475,000 cash, may cover operating costs until lon
ger term capital is obtained to finance the  Company&#8217;s future development. There is no assurance that this can be accomplished on terms satisfactory to the Company.</font><br><br><font size="2"><b>Item 3.&nbsp;&nbsp;&nbsp;Controls and Procedures</b></font><br><br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company&#8217;s president currently acts both as its chief executive officer and chief financial officer and is responsible for establishing and  maintaining disclosure controls and procedures designed to ensure that information required to be disclosed by the Company in the reports filed  under the Securities Exchange Act, is recorded, processed, summarized and reported within the time periods specified by the SEC&#8217;s rules and  forms. Disclosure controls are also designed with the objective of ensuring that this information is accumulated and communicated to the  Company&#8217;s management, including the Company&#8217;s chief executive officer and chief financial officer, as ap
propriate, to allow timely decisions </font><br><font size="2">regarding required disclosure.</font><br><br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the  internal control system are met. Because of the inherent limitations of any internal control system, no evaluation of controls can provide absolute </font><br><font size="2">assurance that all control issues, if any, within a company have been detected.</font><br><br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Management did not use a framework to conduct the required evaluation of the effectiveness of the Company&#8217;s  internal control over  financial reporting since, in the view of management, comparison with a framework was unwarranted because the size of the Company&#8217;s current  operations are such that management is aware of all current transactions and also that the size of the Com
pany prevents it from being able to  employ sufficient staffing resources to enable the Company to have adequate segregation of duties within its internal control system.  </font><br><br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;An evaluation was conducted by the Company&#8217;s president as to the effectiveness of the design and operation of the Company&#8217;s disclosure  controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the quarterly period ending January 31,  2008 covered by this Quarterly Report on Form 10-QSB. Based upon such evaluation, the Company&#8217;s president concluded that, as of the end of  such period, the Company&#8217;s disclosure controls and procedures were not effective as required under Rules 13a-15(e) and 15d-15(e) under the </font><br><font size="2">Exchange Act. </font><br><br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This deficiency consists primarily of inadequate staffing and supervision that could lea
d to the untimely identification and resolution of  accounting and disclosure matters and failure to perform timely and effective reviews. However, the size of the Company prevents it from being  able to employ sufficient resources to enable the Company to have adequate segregation of duties within its internal control system. Management  is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. When the Company is able to  obtain sufficient funding and develop its management and staffing, it will apply the necessary corrective action to remedy the weakness.</font><br><br><br></p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center" style="border-bottom:double">
<font size="2">19</font></p>
</td>
</tr>
</table></div>
<p>
<br><br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There was no change in the Company&#8217;s internal control over financial reporting that occurred during the period covered by this Quarterly  Report on Form 10-QSB that has materially affected, or is reasonably likely to materially affect, the Company&#8217;s internal control over financial  reporting.</font><br><br><font size="2"><b>Critical Accounting Policies</b></font><br><br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the notes to the condensed consolidated financial statements for the quarter ended January 31, 2008 included in the Company&#8217;s  Form 10-QSB, the Company discussed those accounting policies that are considered to be significant in determining the results of  operations and our financial position. We believe that the accounting principles utilized by us conform to accounting principles generally  accepted in the United States of America<b>.</b></font><br><br><br><font size="2"><b>Part II.&nbsp;&nbsp;&nbsp
;Other Information</b></font><br><br><font size="2"><b>Item 6.&nbsp;&nbsp;&nbsp;Exhibits </b></font><br><br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;31.1	Certification of the Chief Executive and Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a).</font><br><br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;31.2	Certification of the Chief Executive and Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. 1350.</font></p>
<p>
<p>
<font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;32.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section
1350 Certifications</font></p>
<p>
<br><br></p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center" style="border-bottom:double">
<font size="2">20</font></p>
</td>
</tr>
</table></div>
<p>
<br><br></p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>SIGNATURES</b></font></p align="center">
</td>
</tr>
</table></div>
<p>
<br><br><font size="2">Pursuant to the requirements of Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the  undersigned hereunto duly authorized.</font><br></p>
<div style="position:relative; left: 0"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="389.333236" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="262.666601" colspan="1" rowspan="1" >
<p>
<font size="2"><b>CHAMPIONS BIOTECHNOLOGY, INC.</b></font></p>
</td>
<td width="5.333332" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="659.999835" colspan="3" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="659.999835" colspan="3" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="389.333236" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="262.666601" colspan="1" rowspan="1" >
<p>
<font size="2"><u>/s/ Douglas D. Burkett</u></font></p>
</td>
<td width="5.333332" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="389.333236" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="269.333266" colspan="2" rowspan="1" >
<p>
<font size="2">Douglas D. Burkett</font></p>
</td>
</tr>
<tr valign="top">
<td width="389.333236" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="269.333266" colspan="2" rowspan="1" >
<p>
<font size="2">Principal Executive Officer</font></p>
</td>
</tr>
<tr valign="top">
<td width="659.999835" colspan="3" rowspan="1" >
<p>
<font size="2">Date: August 1, 2008</font></p>
</td>
</tr>
</table></div>
<p>
<br><br></p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center" style="border-bottom:double">
<font size="2">21</font></p>
</td>
</tr>
</table></div>
<p>
<br><br></p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>Section 302 Certification</b></font></p align="center">
</td>
</tr>
</table></div>
<p>
<br><font size="2">I, DOUGLAS D. BURKETT, certify that:</font><br><br><font size="2">(1) I have reviewed this quarterly report on Form 10-QSB of CHAMPIONS BIOTECHNOLOGY, INC., a Delaware corporation (the  "registrant");</font><br><br><font size="2">(2) Based on my  knowledge,  this  quarterly  report does not contain any untrue statement of a material fact or omit to state a material fact   necessary to make the statements made, in light of the  circumstances  under which such statements were made, not  misleading  with respect to  the period covered by this quarterly report;</font><br><br><font size="2">(3) Based on my  knowledge,  the  financial  statements,  and  other  financial information  included in this quarterly  report,  fairly present in all  material respects the financial  condition,  results of operations  and cash flows of the registrant as of, and for, the periods presented in this  quarterly report;</font><br><br><font size="2">(4) The  registrant&#8217;s  other  certifying  officers  and I
 are  responsible  for establishing and maintaining  disclosure  controls and procedures (as  defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and have:</font><br><br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated   subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being   prepared;</font><br><br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and  procedures  as of a date  within 90 days prior to the  filing  date of  this  quarterly report (the "Evaluation Date"); and    </font><br><br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Presented  in  this  quarterly   report  our  conclusions   about  the effectiveness  of the  disclosure  controls  and  proced
ures  based  on  our evaluation as of the Evaluation Date;  </font><br><br><font size="2">(5) The registrant&#8217;s other certifying officers and I have disclosed, based on our most recent evaluation, to the registrant&#8217;s auditors and the audit  committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):</font><br><br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) all  significant  deficiencies  in the design or  operation of internal controls which could adversely affect the registrant&#8217;s ability to record,   process,  summarize and report  financial data and have  identified for the registrant&#8217;s auditors any material weaknesses in internal controls; and</font><br><br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) any fraud,  whether or not material,  that involves management or other employees who have a significant  role  in  the  registrant&#8217;s   internal controls; and  </font><br><br><font size="2">(6) The regi
strant&#8217;s  other  certifying  officers and I have  indicated in this quarterly report whether there were significant  changes in internal  controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent  evaluation,  including any  corrective  actions with regard to significant deficiencies and material weaknesses.  Date:  August 1, 2008 </font><br><br></p>
<div style="position:relative; left: 0"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="443.999889" colspan="1" rowspan="1" >
<p>
<font size="2">By:&nbsp;</font></p>
</td>
<td width="143.999964" colspan="1" rowspan="1" >
<p style="border-bottom:solid windowtext .5pt">
<font size="2">/s/ Douglas D. Burkett</font></p>
</td>
<td width="23.999994" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="443.999889" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="167.999958" colspan="2" rowspan="1" >
<p>
<font size="2">Douglas D. Burkett</font></p>
</td>
</tr>
<tr valign="top">
<td width="443.999889" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="167.999958" colspan="2" rowspan="1" >
<p>
<font size="2">Principal Executive Officer</font></p>
</td>
</tr>
</table></div>
<p>
<br><br></p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center" style="border-bottom:double">
<font size="2">22</font></p>
</td>
</tr>
</table></div>
<p>
 <br></p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>CERTIFICATION OF CHIEF FINANCIAL OFFICER</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>Section 302 Certification</b></font></p align="center">
</td>
</tr>
</table></div>
<p>
<br><br><font size="2"> </font> <font size="2">I, DURWOOD C. SETTLES, certify that: </font> <br><br><font size="2">(1) I have reviewed this quarterly report on Form 10-QSB of CHAMPIONS BIOTECHNOLOGY, INC., a Delaware corporation (the  "registrant");  </font><br><br><font size="2">(2) Based on my knowledge, this  quarterly  report does not contain any untrue statement of a material fact or omit to state a material fact   necessary to make the statements made, in light of the  circumstances  under which such statements were made, not  misleading  with respect to  the period covered by this quarterly report.  </font><br><br><font size="2">(3) Based on my  knowledge,  the  financial  statements,  and  other  financial information  included in this quarterly  report,  fairly present in all  material respects the financial  condition,  results of operations  and cash flows of the registrant as of, and for, the periods presented in this  quarterly report;   </font><br><br><font size="2">(4) The  registrant&#8217;s 
 other  certifying  officers  and I are  responsible  for establishing and maintaining  disclosure  controls and procedures (as  defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and have:  </font><br><br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Designed  such  disclosure  controls  and  procedures  to ensure  that  material information relating to the registrant, including its  consolidated subsidiaries, is  made  known  to  us by  others  within  those  entities, particularly  during  the period in which  this  quarterly   report is being  prepared;  </font><br><br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures  as of a date  within 90 days prior to the  filing  date of  this quarterly report (the "Evaluation Date"); and  </font><br><br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)  Presented  in  this  quarterly   report  our  conclusions   about  the 
effectiveness  of the  disclosure  controls  and  procedures  based  on  our evaluation as of the Evaluation Date;  </font><br><br><font size="2">(5) The registrant&#8217;s other certifying officers and I have disclosed, based on our most recent evaluation, to the registrant&#8217;s auditors and the audit  committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions):  </font><br><br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) all  significant  deficiencies  in the design or  operation of internal controls which could adversely affect the  registrant&#8217;s  ability to  record, process,  summarize and report  financial data and have  identified for the registrant&#8217;s auditors any material weaknesses in internal  controls; and  </font><br><br><font size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) any fraud,  whether or not material,  that involves management or other employees who have a significant  role  in  the  registrant&#8217;s   inte
rnal controls; and  </font><br><br><font size="2">(6) The registrant&#8217;s other certifying officers and I have indicated in this quarterly report whether there were significant changes in internal  controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any  corrective actions with regard to significant deficiencies and material weaknesses.  Date: August 1, 2008 </font><br><br></p>
<div style="position:relative; left: 0"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="431.999892" colspan="1" rowspan="1" >
<p>
<font size="2">By:&nbsp;</font></p>
</td>
<td width="167.999958" colspan="1" rowspan="1" >
<p style="border-bottom:solid windowtext .5pt">
<font size="2">/s/ Durwood C. Settles</font></p>
</td>
<td width="35.999991" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="431.999892" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="203.999949" colspan="2" rowspan="1" >
<p>
<font size="2">Durwood C. Settles</font></p>
</td>
</tr>
<tr valign="top">
<td width="431.999892" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="203.999949" colspan="2" rowspan="1" >
<p>
<font size="2">Chief Financial Officer</font></p>
</td>
</tr>
</table></div>
<p>
<br><br><br></p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center" style="border-bottom:double">
<font size="2">23</font></p>
</td>
</tr>
</table></div>
<p>
<br></p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO</b></font></p align="center">
</td>
</tr>
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center">
<font size="2"><b>SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</b></font></p align="center">
</td>
</tr>
</table></div>
<p>
<br><br><font size="2">In connection with the quarterly report of Champions Biotechnology, Inc. (the "Company") on Form 10-QSB for the nine months ended January  31, 2008 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), each of the undersigned, in the capacities and  on the dates indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act  of 2002, that to their knowledge:  </font><br><br><font size="2">1.	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and   </font><br><br><font size="2">2.	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the  Company.  </font> <br><br></p>
<div style="position:relative; left: 0"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="419.999895" colspan="1" rowspan="1" >
<p>
<font size="2">Date: August 1, 2008</font></p>
</td>
<td width="101.333308" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="154.666628" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="55.999986" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="419.999895" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="101.333308" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="154.666628" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="55.999986" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="419.999895" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="101.333308" colspan="1" rowspan="1" >
<p align="right">
<font size="2">By:&nbsp;</font></p align="right">
</td>
<td width="154.666628" colspan="1" rowspan="1" >
<p style="border-bottom:solid windowtext .5pt">
<font size="2">/s/ Douglas D. Burkett</font></p>
</td>
<td width="55.999986" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="419.999895" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="101.333308" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="154.666628" colspan="1" rowspan="1" >
<p>
<font size="2">Douglas D. Burkett</font></p>
</td>
<td width="55.999986" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="419.999895" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="101.333308" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="154.666628" colspan="1" rowspan="1" >
<p>
<font size="2">Principal Executive Officer</font></p>
</td>
<td width="55.999986" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="419.999895" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="101.333308" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="154.666628" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="55.999986" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="419.999895" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="101.333308" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="154.666628" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="55.999986" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="419.999895" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="101.333308" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="154.666628" colspan="1" rowspan="1" >
<p>
<font size="2"><u>/s/Durwood C. Settles</u></font></p>
</td>
<td width="55.999986" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="419.999895" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="101.333308" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="154.666628" colspan="1" rowspan="1" >
<p>
<font size="2">Durwood C. Settles</font></p>
</td>
<td width="55.999986" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
<tr valign="top">
<td width="419.999895" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="101.333308" colspan="1" rowspan="1" >
&nbsp;</td>
<td width="154.666628" colspan="1" rowspan="1" >
<p>
<font size="2">Chief Financial Officer</font></p>
</td>
<td width="55.999986" colspan="1" rowspan="1" >
&nbsp;</td>
</tr>
</table></div>
<p>
<br><br></p align="center">
<div align="center" style="position:relative; left: -5"><table border=0 cellpadding=0 cellspacing =0 >
<tr valign="top">
<td width="714.666488" colspan="1" rowspan="1" >
<p align="center" style="border-bottom:double">
<font size="2">24</font></p>
</td>
</tr>
</table></div>
<p>
</p>


</body>

</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
